| Year |
Citation |
Score |
| 2019 |
Bravo-San Pedro JM, Sica V, Kroemer G. The elusive "hunger protein": an appetite-stimulatory factor that is overabundant in human obesity. Molecular & Cellular Oncology. 6: e1667193. PMID 31692883 DOI: 10.1080/23723556.2019.1667193 |
1 |
|
| 2019 |
Pedro JMB, Sica V, Madeo F, Kroemer G. Acyl-CoA-binding protein (ACBP): the elusive 'hunger factor' linking autophagy to food intake. Cell Stress. 3: 312-318. PMID 31656948 DOI: 10.15698/cst2019.10.200 |
1 |
|
| 2019 |
Lévesque S, Le Naour J, Pietrocola F, Paillet J, Kremer M, Castoldi F, Baracco EE, Wang Y, Vacchelli E, Stoll G, Jolly A, De La Grange P, Zitvogel L, Kroemer G, Pol JG. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. Oncoimmunology. 8: e1657375. PMID 31646107 DOI: 10.1080/2162402X.2019.1657375 |
0.96 |
|
| 2019 |
Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 8: e1638212. PMID 31646087 DOI: 10.1080/2162402X.2019.1638212 |
1 |
|
| 2019 |
Pietrocola F, Kroemer G. Caloric restriction promotes the stemness and antitumor activity of T lymphocytes. Oncoimmunology. 8: e1616153. PMID 31646069 DOI: 10.1080/2162402X.2019.1616153 |
0.96 |
|
| 2019 |
Chen G, Xie W, Nah J, Sauvat A, Liu P, Pietrocola F, Sica V, Carmona-Gutierrez D, Zimmermann A, Pendl T, Tadic J, Bergmann M, Hofer SJ, Domuz L, Lachkar S, ... ... Kroemer G, et al. 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB. Embo Molecular Medicine. e10469. PMID 31609086 DOI: 10.15252/emmm.201910469 |
1 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Kroemer G. Pseudodiabetes-not a contraindication for metabolic interventions. Cell Death & Disease. 10: 765. PMID 31601789 DOI: 10.1038/s41419-019-2007-1 |
1 |
|
| 2019 |
Loos F, Xie W, Sica V, Bravo-San Pedro JM, Souquère S, Pierron G, Lachkar S, Sauvat A, Petrazzuolo A, Jimenez AJ, Perez F, Maiuri MC, Kepp O, Kroemer G. Artificial tethering of LC3 or p62 to organelles is not sufficient to trigger autophagy. Cell Death & Disease. 10: 771. PMID 31601788 DOI: 10.1038/s41419-019-2011-5 |
1 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Martins I, Anagnostopoulos G, Maiuri C, Kroemer G. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. Autophagy. PMID 31470770 DOI: 10.1080/15548627.2019.1662585 |
1 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Kroemer G. A strategy for poisoning cancer cell metabolism: Inhibition of oxidative phosphorylation coupled to anaplerotic saturation. International Review of Cell and Molecular Biology. 347: 27-37. PMID 31451215 DOI: 10.1016/bs.ircmb.2019.07.002 |
1 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Kroemer G, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. PMID 31422903 DOI: 10.1016/j.cmet.2019.07.010 |
1 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. International Journal of Cancer. PMID 31396957 DOI: 10.1002/ijc.32616 |
1 |
|
| 2019 |
Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 20: e452-e463. PMID 31364597 DOI: 10.1016/S1470-2045(19)30171-8 |
1 |
|
| 2019 |
Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism. 30: 36-50. PMID 31269428 DOI: 10.1016/j.cmet.2019.06.001 |
1 |
|
| 2019 |
Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Carmona-Gutierrez D, Kroemer G. 4,4'-Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effects. Autophagy. I-3. PMID 31248332 DOI: 10.1080/15548627.2019.1632623 |
0.96 |
|
| 2019 |
Baracco EE, Castoldi F, Durand S, Enot DP, Tadic J, Kainz K, Madeo F, Chery A, Izzo V, Maiuri MC, Pietrocola F, Kroemer G. α-Ketoglutarate inhibits autophagy. Aging. PMID 31173576 DOI: 10.18632/aging.102001 |
0.96 |
|
| 2019 |
Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 8: 1591878. PMID 31143510 DOI: 10.1080/2162402X.2019.1591878 |
1 |
|
| 2019 |
Rao S, Mondragón L, Pranjic B, Hanada T, Stoll G, Köcher T, Zhang P, Jais A, Lercher A, Bergthaler A, Schramek D, Haigh K, Sica V, Leduc M, Modjtahedi N, ... ... Kroemer G, et al. AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Research. PMID 31133695 DOI: 10.1038/s41422-019-0181-4 |
1 |
|
| 2019 |
Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Kroemer G, Carmona-Gutierrez D. Targeting GATA transcription factors - a novel strategy for anti-aging interventions? Microbial Cell (Graz, Austria). 6: 212-216. PMID 31114793 DOI: 10.15698/mic2019.05.676 |
0.96 |
|
| 2019 |
Stoll G, Kremer M, Bloy N, Joseph A, Castedo M, Meurice G, Klein C, Galluzzi L, Michels J, Kroemer G. Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 8: e1571389. PMID 31069148 DOI: 10.1080/2162402X.2019.1571389 |
1 |
|
| 2019 |
Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1883. PMID 30996258 DOI: 10.1038/s41467-019-09838-y |
1 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, ... ... Kroemer G, et al. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell Reports. 27: 820-834.e9. PMID 30995479 DOI: 10.1016/j.celrep.2019.03.058 |
1 |
|
| 2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. PMID 30962044 DOI: 10.1016/j.tcb.2019.03.005 |
1 |
|
| 2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. 29: 449-451. PMID 30962043 DOI: 10.1016/j.tcb.2019.03.002 |
1 |
|
| 2019 |
Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1486. PMID 30940805 DOI: 10.1038/s41467-019-09415-3 |
1 |
|
| 2019 |
Galluzzi L, Kroemer G. Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & Cellular Oncology. 6: 1558874. PMID 30788425 DOI: 10.1080/23723556.2018.1558874 |
1 |
|
| 2019 |
Carmona-Gutierrez D, Zimmermann A, Kainz K, Pietrocola F, Chen G, Maglioni S, Schiavi A, Nah J, Mertel S, Beuschel CB, Castoldi F, Sica V, Trausinger G, Raml R, Sommer C, ... ... Kroemer G, et al. The flavonoid 4,4'-dimethoxychalcone promotes autophagy-dependent longevity across species. Nature Communications. 10: 651. PMID 30783116 DOI: 10.1038/s41467-019-08555-w |
1 |
|
| 2019 |
Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 8: e1505174. PMID 30546943 DOI: 10.1080/2162402X.2018.1505174 |
0.96 |
|
| 2019 |
Castoldi F, Vacchelli E, Zitvogel L, Maiuri MC, Pietrocola F, Kroemer G. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology. 8: e1498285. PMID 30546941 DOI: 10.1080/2162402X.2018.1498285 |
0.96 |
|
| 2019 |
Humeau J, Lévesque S, Kroemer G, Pol JG. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models. Methods in Molecular Biology (Clifton, N.J.). 1884: 297-315. PMID 30465212 DOI: 10.1007/978-1-4939-8885-3_21 |
0.52 |
|
| 2018 |
Rodriguez J, Zhang Y, Li T, Xie C, Sun Y, Xu Y, Zhou K, Huo K, Wang Y, Wang X, Andersson D, Ståhlberg A, Xing Q, Mallard C, Hagberg H, ... ... Kroemer G, et al. Lack of the brain-specific isoform of apoptosis-inducing factor aggravates cerebral damage in a model of neonatal hypoxia-ischemia. Cell Death & Disease. 10: 3. PMID 30584234 DOI: 10.1038/s41419-018-1250-1 |
0.68 |
|
| 2018 |
Pechlaner R, Madeo F, Eisenberg T, Kroemer G, Tilg H, Willeit J, Kiechl S. Reply to Gostner and Fuchs. The American Journal of Clinical Nutrition. PMID 30576412 DOI: 10.1093/ajcn/nqy222 |
0.88 |
|
| 2018 |
Castedo M, Obrist F, Kroemer G. Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions. Molecular & Cellular Oncology. 5: e1526004. PMID 30525097 DOI: 10.1080/23723556.2018.1526004 |
0.96 |
|
| 2018 |
Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate. Oncoimmunology. 7: e1528815. PMID 30524910 DOI: 10.1080/2162402X.2018.1528815 |
1 |
|
| 2018 |
Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 7: e1526250. PMID 30524908 DOI: 10.1080/2162402X.2018.1526250 |
1 |
|
| 2018 |
Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 7: e1511506. PMID 30524907 DOI: 10.1080/2162402X.2018.1511506 |
1 |
|
| 2018 |
G Pol J, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, R Clements D, Fahrner JE, Fend L, C Bell J, L Mossman K, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 7: e1503032. PMID 30524901 DOI: 10.1080/2162402X.2018.1503032 |
1 |
|
| 2018 |
Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, ... ... Kroemer G, et al. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. Oncoimmunology. 7: e1386826. PMID 30524877 DOI: 10.1080/2162402X.2017.1386826 |
0.88 |
|
| 2018 |
López-Soto A, Kroemer G. Cancer-Induced Endoplasmic Reticulum Stress in T Cells Subverts Immunosurveillance. Cell Metabolism. 28: 803-805. PMID 30517892 DOI: 10.1016/j.cmet.2018.11.003 |
0.32 |
|
| 2018 |
Marchi S, Corricelli M, Branchini A, Vitto VAM, Missiroli S, Morciano G, Perrone M, Ferrarese M, Giorgi C, Pinotti M, Galluzzi L, Kroemer G, Pinton P. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth. The Embo Journal. PMID 30504268 DOI: 10.15252/embj.201899435 |
1 |
|
| 2018 |
Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, ... ... Kroemer G, et al. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. The Embo Journal. PMID 30498130 DOI: 10.15252/embj.2018100101 |
0.44 |
|
| 2018 |
Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, ... ... Kroemer G, et al. Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology. PMID 30452922 DOI: 10.1053/j.gastro.2018.11.032 |
0.96 |
|
| 2018 |
Sixt BS, Núñez-Otero C, Kepp O, Valdivia RH, Kroemer G. Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death and Differentiation. PMID 30375511 DOI: 10.1038/s41418-018-0224-2 |
0.96 |
|
| 2018 |
Abdellatif M, Sedej S, Carmona-Gutierrez D, Madeo F, Kroemer G. Autophagy in Cardiovascular Aging. Circulation Research. 123: 803-824. PMID 30355077 DOI: 10.1161/CIRCRESAHA.118.312208 |
0.88 |
|
| 2018 |
Pietrocola F, Castoldi F, Kepp O, Carmona-Gutierrez D, Madeo F, Kroemer G. Spermidine reduces cancer-related mortality in humans. Autophagy. 1-4. PMID 30354939 DOI: 10.1080/15548627.2018.1539592 |
0.96 |
|
| 2018 |
Zhou H, Mondragón L, Xie W, Mauseth B, Leduc M, Sauvat A, Gomes-da-Silva LC, Forveille S, Iribarren K, Souquere S, Bezu L, Liu P, Zhao L, Zitvogel L, Sveinbjørnsson B, ... ... Kroemer G, et al. Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death & Disease. 9: 1086. PMID 30352991 DOI: 10.1038/s41419-018-1127-3 |
0.96 |
|
| 2018 |
Gomes-da-Silva LC, Jimenez AJ, Sauvat A, Xie W, Souquere S, Divoux S, Storch M, Sveinbjørnsson B, Rekdal Ø, Arnaut LG, Kepp O, Kroemer G, Perez F. Recruitment of LC3 to damaged Golgi apparatus. Cell Death and Differentiation. PMID 30349077 DOI: 10.1038/s41418-018-0221-5 |
0.96 |
|
| 2018 |
Kroemer G, López-Otín C, Madeo F, de Cabo R. Carbotoxicity-Noxious Effects of Carbohydrates. Cell. 175: 605-614. PMID 30340032 DOI: 10.1016/j.cell.2018.07.044 |
0.88 |
|
| 2018 |
Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B. The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes. 1-5. PMID 30339501 DOI: 10.1080/19490976.2018.1527167 |
0.88 |
|
| 2018 |
Madeo F, Bauer MA, Carmona-Gutierrez D, Kroemer G. Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy. 1-4. PMID 30306826 DOI: 10.1080/15548627.2018.1530929 |
0.88 |
|
| 2018 |
Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nature Reviews. Molecular Cell Biology. PMID 30305710 DOI: 10.1038/s41580-018-0068-0 |
1 |
|
| 2018 |
Zhao L, Liu P, Boncompain G, Loos F, Lachkar S, Bezu L, Chen G, Zhou H, Perez F, Kepp O, Kroemer G. Identification of pharmacological inhibitors of conventional protein secretion. Scientific Reports. 8: 14966. PMID 30297865 DOI: 10.1038/s41598-018-33378-y |
0.96 |
|
| 2018 |
Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G. Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts. Oncoimmunology. 7: e1484980. PMID 30288345 DOI: 10.1080/2162402X.2018.1484980 |
0.88 |
|
| 2018 |
Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-Soto A. The hallmarks of successful anticancer immunotherapy. Science Translational Medicine. 10. PMID 30232229 DOI: 10.1126/scitranslmed.aat7807 |
1 |
|
| 2018 |
Enot DP, Vacchelli E, Jacquelot N, Zitvogel L, Kroemer G. TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves. Oncoimmunology. 7: e1462431. PMID 30228932 DOI: 10.1080/2162402X.2018.1462431 |
0.92 |
|
| 2018 |
Aranda F, Chaba K, Bloy N, Garcia P, Bordenave C, Martins I, Stoll G, Tesniere A, Kroemer G, Senovilla L. Immune effectors responsible for the elimination of hyperploid cancer cells. Oncoimmunology. 7: e1463947. PMID 30221060 DOI: 10.1080/2162402X.2018.1463947 |
0.92 |
|
| 2018 |
Bonora M, Wieckowski MR, Sinclair DA, Kroemer G, Pinton P, Galluzzi L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature Reviews. Cardiology. PMID 30177752 DOI: 10.1038/s41569-018-0074-0 |
1 |
|
| 2018 |
Bárcena C, Quirós PM, Durand S, Mayoral P, Rodríguez F, Caravia XM, Mariño G, Garabaya C, Fernández-García MT, Kroemer G, Freije JMP, López-Otín C. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism. Cell Reports. 24: 2392-2403. PMID 30157432 DOI: 10.1016/j.celrep.2018.07.089 |
0.8 |
|
| 2018 |
Gomes-da-Silva LC, Zhao L, Arnaut LG, Kroemer G, Kepp O. Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus. Oncotarget. 9: 31169-31170. PMID 30131844 DOI: 10.18632/oncotarget.25798 |
0.96 |
|
| 2018 |
Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR, Mallucci GR, Kroemer G, Levine B, Eskelinen EL, Mochel F, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nature Reviews. Drug Discovery. PMID 30116051 DOI: 10.1038/nrd.2018.109 |
0.6 |
|
| 2018 |
Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen Q, Xie Y, Liu J, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Developmental Cell. PMID 30100261 DOI: 10.1016/j.devcel.2018.07.012 |
0.64 |
|
| 2018 |
Madeo F, Gutierrez DC, Kepp O, Kroemer G. Spermidine delays aging in humans. Aging. PMID 30082504 DOI: 10.18632/aging.101517 |
0.96 |
|
| 2018 |
Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G, Lotze MT, Zeh HJ, Kang R, Tang D. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X Activity. Current Biology : Cb. PMID 30057310 DOI: 10.1016/j.cub.2018.05.094 |
0.64 |
|
| 2018 |
Kiechl S, Pechlaner R, Willeit P, Notdurfter M, Paulweber B, Willeit K, Werner P, Ruckenstuhl C, Iglseder B, Weger S, Mairhofer B, Gartner M, Kedenko L, Chmelikova M, Stekovic S, ... ... Kroemer G, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. The American Journal of Clinical Nutrition. PMID 29955838 DOI: 10.1093/ajcn/nqy102 |
0.88 |
|
| 2018 |
Deretic V, Prossnitz E, Burge M, Campen MJ, Cannon J, Liu KJ, Sklar LA, Allers L, Garcia SA, Baehrecke EH, Behrends C, Cecconi F, Codogno P, Chen GC, Elazar Z, ... ... Kroemer G, et al. Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations. Autophagy. PMID 29938597 DOI: 10.1080/15548627.2018.1465784 |
0.56 |
|
| 2018 |
Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, Cao L, Xie M, Ran Q, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D. Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. Cell Host & Microbe. PMID 29937272 DOI: 10.1016/j.chom.2018.05.009 |
0.64 |
|
| 2018 |
Pietrocola F, Castoldi F, Maiuri MC, Kroemer G. Aspirin-another caloric-restriction mimetic. Autophagy. PMID 29929449 DOI: 10.1080/15548627.2018.1454810 |
0.96 |
|
| 2018 |
Sica V, Kroemer G. Author Correction: IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29921919 DOI: 10.1038/s41422-018-0059-x |
1 |
|
| 2018 |
Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, ... ... Kroemer G, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death & Disease. 9: 716. PMID 29915308 DOI: 10.1038/s41419-018-0747-y |
0.92 |
|
| 2018 |
Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G. Metabolic vulnerability of cisplatin-resistant cancers. The Embo Journal. PMID 29875130 DOI: 10.15252/embj.201798597 |
0.96 |
|
| 2018 |
Derosa L, Routy B, Kroemer G, Zitvogel L. The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1. Oncoimmunology. 7: e1434468. PMID 29872574 DOI: 10.1080/2162402X.2018.1434468 |
0.88 |
|
| 2018 |
García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 7: e1433982. PMID 29872569 DOI: 10.1080/2162402X.2018.1433982 |
1 |
|
| 2018 |
Liu P, Zhao L, Loos F, Iribarren K, Kepp O, Kroemer G. Epigenetic anticancer agents cause HMGB1 release . Oncoimmunology. 7: e1431090. PMID 29872561 DOI: 10.1080/2162402X.2018.1431090 |
0.96 |
|
| 2018 |
Bezu L, Sauvat A, Humeau J, Leduc M, Kepp O, Kroemer G. eIF2α phosphorylation: A hallmark of immunogenic cell death. Oncoimmunology. 7: e1431089. PMID 29872560 DOI: 10.1080/2162402X.2018.1431089 |
0.96 |
|
| 2018 |
Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, Tang D, Kang R. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 7: e1431086. PMID 29872558 DOI: 10.1080/2162402X.2018.1431086 |
0.64 |
|
| 2018 |
Castoldi F, Pietrocola F, Maiuri MC, Kroemer G. Aspirin induces autophagy inhibition of the acetyltransferase EP300. Oncotarget. 9: 24574-24575. PMID 29872488 DOI: 10.18632/oncotarget.25364 |
0.96 |
|
| 2018 |
Sica V, Kroemer G. IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29844577 DOI: 10.1038/s41422-018-0051-5 |
1 |
|
| 2018 |
Gomes-da-Silva LC, Zhao L, Bezu L, Zhou H, Sauvat A, Liu P, Durand S, Leduc M, Souquere S, Loos F, Mondragón L, Sveinbjørnsson B, Rekdal Ø, Boncompain G, Perez F, ... ... Kroemer G, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. The Embo Journal. PMID 29807932 DOI: 10.15252/embj.201798354 |
0.96 |
|
| 2018 |
Kang R, Kroemer G, Tang D. The Tumor Suppressor Protein p53 and the Ferroptosis Network. Free Radical Biology & Medicine. PMID 29800655 DOI: 10.1016/j.freeradbiomed.2018.05.074 |
0.64 |
|
| 2018 |
Rossin F, Villella VR, D'Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, et al. TG2 regulates the heat-shock response by the post-translational modification of HSF1. Embo Reports. PMID 29752334 DOI: 10.15252/embr.201745067 |
0.44 |
|
| 2018 |
Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nature Reviews. Clinical Oncology. PMID 29636538 DOI: 10.1038/s41571-018-0006-2 |
0.88 |
|
| 2018 |
Sauvat A, Chen G, Müller K, Tong M, Aprahamian F, Durand S, Cerrato G, Bezu L, Leduc M, Franz J, Rockenfeller P, Sadoshima J, Madeo F, Kepp O, Kroemer G. Trans-Fats Inhibit Autophagy Induced by Saturated Fatty Acids. Ebiomedicine. PMID 29606629 DOI: 10.1016/j.ebiom.2018.03.028 |
0.96 |
|
| 2018 |
Pol J, Kroemer G. Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacy. Cell Research. 28: 501-502. PMID 29593340 DOI: 10.1038/s41422-018-0031-9 |
0.6 |
|
| 2018 |
Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science (New York, N.Y.). 359: 1366-1370. PMID 29567708 DOI: 10.1126/science.aar6918 |
0.88 |
|
| 2018 |
Perez-Lanzon M, Kroemer G, Maiuri MC. Organoids for Modeling Genetic Diseases. International Review of Cell and Molecular Biology. 337: 49-81. PMID 29551162 DOI: 10.1016/bs.ircmb.2017.12.006 |
0.96 |
|
| 2018 |
Pietrocola F, Castoldi F, Markaki M, Lachkar S, Chen G, Enot DP, Durand S, Bossut N, Tong M, Malik SA, Loos F, Dupont N, Mariño G, Abdelkader N, Madeo F, ... ... Kroemer G, et al. Aspirin Recapitulates Features of Caloric Restriction. Cell Reports. 22: 2395-2407. PMID 29490275 DOI: 10.1016/j.celrep.2018.02.024 |
0.96 |
|
| 2018 |
Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nature Cell Biology. 20: 243-251. PMID 29476153 DOI: 10.1038/s41556-018-0042-2 |
1 |
|
| 2018 |
Zhang S, Stoll G, Pedro JMBS, Sica V, Sauvat A, Obrist F, Kepp O, Li Y, Maiuri L, Zamzami N, Kroemer G. Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR. Cell Death & Disease. 9: 191. PMID 29415993 DOI: 10.1038/s41419-017-0235-9 |
1 |
|
| 2018 |
Kroemer G, Zitvogel L. Cancer immunotherapy in 2017: The breakthrough of the microbiota. Nature Reviews. Immunology. 18: 87-88. PMID 29379189 DOI: 10.1038/nri.2018.4 |
0.88 |
|
| 2018 |
Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science (New York, N.Y.). 359. PMID 29371440 DOI: 10.1126/science.aan2788 |
0.96 |
|
| 2018 |
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, ... ... Kroemer G, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation. PMID 29362479 DOI: 10.1038/s41418-017-0012-4 |
1 |
|
| 2018 |
Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S, Garcia P, Zhao L, Liu P, Zitvogel L, Senovilla L, Kepp O, Kroemer G. eIF2α phosphorylation is pathognomonic for immunogenic cell death. Cell Death and Differentiation. PMID 29358668 DOI: 10.1038/s41418-017-0044-9 |
0.96 |
|
| 2018 |
Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Kroemer G, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/mic2018.01.607 |
1 |
|
| 2018 |
Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Høyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J, Jäättelä M. Correction for Gyrd-Hansen et al., "Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9". Molecular and Cellular Biology. 38. PMID 29288151 DOI: 10.1128/MCB.00563-17 |
0.44 |
|
| 2017 |
Kroemer G, Galluzzi L. Lysosome-targeting agents in cancer therapy. Oncotarget. 8: 112168-112169. PMID 29348815 DOI: 10.18632/oncotarget.21451 |
1 |
|
| 2017 |
Pitt JM, Kroemer G, Zitvogel L. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1036: 65-79. PMID 29275465 DOI: 10.1007/978-3-319-67577-0_5 |
0.88 |
|
| 2017 |
Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, Wang P, Ma X, Kroemer G, Bartlett DL, Billiar TR, Lotze M, Zeh H, Kang R, Tang D. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Gastroenterology. PMID 29248440 DOI: 10.1053/j.gastro.2017.12.004 |
0.64 |
|
| 2017 |
Ring J, Rockenfeller P, Abraham C, Tadic J, Poglitsch M, Schimmel K, Westermayer J, Schauer S, Achleitner B, Schimpel C, Moitzi B, Rechberger GN, Sigrist SJ, Carmona-Gutierrez D, Kroemer G, et al. Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin. Microbial Cell (Graz, Austria). 4: 411-422. PMID 29234670 DOI: 10.15698/mic2017.12.603 |
0.88 |
|
| 2017 |
Rockenfeller P, Smolnig M, Diessl J, Bashir M, Schmiedhofer V, Knittelfelder O, Ring J, Franz J, Foessl I, Khan MJ, Rost R, Graier WF, Kroemer G, Zimmermann A, Carmona-Gutierrez D, et al. Diacylglycerol triggers Rim101 pathway-dependent necrosis in yeast: a model for lipotoxicity. Cell Death and Differentiation. PMID 29230001 DOI: 10.1038/s41418-017-0014-2 |
0.88 |
|
| 2017 |
Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. PMID 29219147 DOI: 10.1038/cr.2017.155 |
1 |
|
| 2017 |
Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 6: e1398878. PMID 29209575 DOI: 10.1080/2162402X.2017.1398878 |
1 |
|
| 2017 |
Garg AD, More S, Rufo N, Mece O, Sassano ML, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 6: e1386829. PMID 29209573 DOI: 10.1080/2162402X.2017.1386829 |
1 |
|
| 2017 |
Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 6: e1371896. PMID 29209572 DOI: 10.1080/2162402X.2017.1371896 |
1 |
|
| 2017 |
Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. 8: 89527-89538. PMID 29163768 DOI: 10.18632/oncotarget.19033 |
1 |
|
| 2017 |
Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 6: e1373237. PMID 29147629 DOI: 10.1080/2162402X.2017.1373237 |
1 |
|
| 2017 |
Fournier C, Martin F, Zitvogel L, Kroemer G, Galluzzi L, Apetoh L. Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 6: e1363139. PMID 29147628 DOI: 10.1080/2162402X.2017.1363139 |
1 |
|
| 2017 |
Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, Liu P, Zhao L, Marabelle A, Zitvogel L, ... ... Kroemer G, et al. The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. PMID 29125604 DOI: 10.1038/cdd.2017.148 |
0.96 |
|
| 2017 |
Liu P, Zhao L, Loos F, Iribarren K, Lachkar S, Zhou H, Gomes-da-Silva LC, Chen G, Bezu L, Boncompain G, Perez F, Zitvogel L, Kepp O, Kroemer G. Identification of pharmacological agents that induce HMGB1 release. Scientific Reports. 7: 14915. PMID 29097772 DOI: 10.1038/s41598-017-14848-1 |
0.96 |
|
| 2017 |
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, ... ... Kroemer G, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, N.Y.). PMID 29097494 DOI: 10.1126/science.aan3706 |
0.88 |
|
| 2017 |
Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, ... ... Kroemer G, et al. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological Reviews. 280: 165-174. PMID 29027230 DOI: 10.1111/imr.12582 |
0.88 |
|
| 2017 |
Kepp O, Loos F, Liu P, Kroemer G. Extracellular nucleosides and nucleotides as immunomodulators. Immunological Reviews. 280: 83-92. PMID 29027229 DOI: 10.1111/imr.12571 |
0.96 |
|
| 2017 |
Biselli E, Agliari E, Barra A, Bertani FR, Gerardino A, De Ninno A, Mencattini A, Di Giuseppe D, Mattei F, Schiavoni G, Lucarini V, Vacchelli E, Kroemer G, Di Natale C, Martinelli E, et al. Organs on chip approach: a tool to evaluate cancer -immune cells interactions. Scientific Reports. 7: 12737. PMID 28986543 DOI: 10.1038/s41598-017-13070-3 |
0.92 |
|
| 2017 |
Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nature Reviews. Immunology. PMID 28944771 DOI: 10.1038/nri.2017.99 |
1 |
|
| 2017 |
López-Soto A, Gonzalez S, López-Larrea C, Kroemer G. Immunosurveillance of Malignant Cells with Complex Karyotypes. Trends in Cell Biology. PMID 28939156 DOI: 10.1016/j.tcb.2017.09.001 |
0.32 |
|
| 2017 |
Maiuri L, Raia V, Kroemer G. Strategies for the etiological therapy of cystic fibrosis. Cell Death and Differentiation. PMID 28937684 DOI: 10.1038/cdd.2017.126 |
0.32 |
|
| 2017 |
Stoll G, Caron B, Viara E, Dugourd A, Zinovyev A, Naldi A, Kroemer G, Barillot E, Calzone L. MaBoSS 2.0: an environment for stochastic Boolean modeling. Bioinformatics (Oxford, England). 33: 2226-2228. PMID 28881959 DOI: 10.1093/bioinformatics/btx123 |
0.6 |
|
| 2017 |
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ, Kang R, Kroemer G, Tang D. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Reports. 20: 1692-1704. PMID 28813679 DOI: 10.1016/j.celrep.2017.07.055 |
0.64 |
|
| 2017 |
Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6: e1328341. PMID 28811970 DOI: 10.1080/2162402X.2017.1328341 |
1 |
|
| 2017 |
Humeau J, Bravo-San Pedro JM, Vitale I, Nuñez L, Villalobos C, Kroemer G, Senovilla L. Calcium signaling and cell cycle: Progression or death. Cell Calcium. PMID 28801101 DOI: 10.1016/j.ceca.2017.07.006 |
0.88 |
|
| 2017 |
Fernández ÁF, Bárcena C, Martínez-García GG, Tamargo-Gómez I, Suárez MF, Pietrocola F, Castoldi F, Esteban L, Sierra-Filardi E, Boya P, López-Otín C, Kroemer G, Mariño G. Autophagy couteracts weight gain, lipotoxicity and pancreatic β-cell death upon hypercaloric pro-diabetic regimens. Cell Death & Disease. 8: e2970. PMID 28771229 DOI: 10.1038/cddis.2017.373 |
0.96 |
|
| 2017 |
Xie Y, Zhu S, Zhong M, Yang M, Sun X, Liu J, Kroemer G, Lotze M, Zeh HJ, Kang R, Tang D. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Gastroenterology. PMID 28764929 DOI: 10.1053/j.gastro.2017.07.036 |
0.64 |
|
| 2017 |
Fridman WH, Zitvogel L, Sautès-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nature Reviews. Clinical Oncology. PMID 28741618 DOI: 10.1038/nrclinonc.2017.101 |
0.88 |
|
| 2017 |
Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nature Immunology. 18: 843-850. PMID 28722707 DOI: 10.1038/ni.3754 |
0.96 |
|
| 2017 |
Galluzzi L, Kroemer G. Secondary Necrosis: Accidental No More. Trends in Cancer. 3: 1-2. PMID 28718422 DOI: 10.1016/j.trecan.2016.12.001 |
1 |
|
| 2017 |
Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. PMID 28706153 DOI: 10.18632/oncotarget.19033 |
1 |
|
| 2017 |
Galluzzi L, Kroemer G. Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 6: e1315496. PMID 28680746 DOI: 10.1080/2162402X.2017.1315496 |
1 |
|
| 2017 |
Stekovic S, Ruckenstuhl C, Royer P, Winkler-Hermaden C, Carmona-Gutierrez D, Fröhlich KU, Kroemer G, Madeo F. The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells. Microbial Cell (Graz, Austria). 4: 191-199. PMID 28660203 DOI: 10.15698/mic2017.06.577 |
0.88 |
|
| 2017 |
Galluzzi L, Kroemer G. An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 6: e1313376. PMID 28638742 DOI: 10.1080/2162402X.2017.1313376 |
1 |
|
| 2017 |
Vitale I, Manic G, Castedo M, Kroemer G. Caspase 2 in mitotic catastrophe: The terminator of aneuploid and tetraploid cells. Molecular & Cellular Oncology. 4: e1299274. PMID 28616577 DOI: 10.1080/23723556.2017.1299274 |
0.96 |
|
| 2017 |
Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 0. PMID 28598229 DOI: 10.1080/15548627.2017.1310356 |
1 |
|
| 2017 |
Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, ... ... Kroemer G, et al. Molecular definitions of autophagy and related processes. The Embo Journal. PMID 28596378 DOI: 10.15252/embj.201796697 |
1 |
|
| 2017 |
Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. Embo Reports. PMID 28566520 DOI: 10.15252/embr.201643602 |
1 |
|
| 2017 |
Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circulation Research. 120: 1812-1824. PMID 28546358 DOI: 10.1161/CIRCRESAHA.117.311082 |
1 |
|
| 2017 |
Fend L, Yamazaki T, Remy C, Fahrner C, Gantzer M, Nourtier V, Préville X, Quéméneur E, Kepp O, Adam J, Marabelle A, Pitt JM, Kroemer G, Zitvogel L. Immune checkpoint blockade, immunogenic chemotherapy or IFN-α blockade boost the local and abscopal effects of oncolytic virotherapy. Cancer Research. PMID 28536278 DOI: 10.1158/0008-5472.CAN-16-2165 |
0.96 |
|
| 2017 |
Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nature Reviews. Microbiology. PMID 28529325 DOI: 10.1038/nrmicro.2017.44 |
0.88 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery. PMID 28529316 DOI: 10.1038/nrd.2017.22 |
1 |
|
| 2017 |
Stoll G, Ma Y, Yang H, Kepp O, Zitvogel L, Kroemer G. Pro-necrotic molecules impact local immunosurveillance in human breast cancer. Oncoimmunology. 6: e1299302. PMID 28507808 DOI: 10.1080/2162402X.2017.1299302 |
0.96 |
|
| 2017 |
Sun Y, Li T, Xie C, Xu Y, Zhou K, Rodriguez J, Han W, Wang X, Kroemer G, Modjtahedi N, Blomgren K, Zhu C. Haploinsufficiency in the mitochondrial protein CHCHD4 reduces brain injury in a mouse model of neonatal hypoxia-ischemia. Cell Death & Disease. 8: e2781. PMID 28492551 DOI: 10.1038/cddis.2017.196 |
0.64 |
|
| 2017 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: Immunosuppressive cell death in cancer. Nature Reviews. Immunology. PMID 28480896 DOI: 10.1038/nri.2017.48 |
1 |
|
| 2017 |
Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L. DNA Damage in Stem Cells. Molecular Cell. 66: 306-319. PMID 28475867 DOI: 10.1016/j.molcel.2017.04.006 |
1 |
|
| 2017 |
Esteban-Martínez L, Sierra-Filardi E, McGreal RS, Salazar-Roa M, Mariño G, Seco E, Durand S, Enot D, Graña O, Malumbres M, Cvekl A, Cuervo AM, Kroemer G, Boya P. Programmed mitophagy is essential for the glycolytic switch during cell differentiation. The Embo Journal. PMID 28465321 DOI: 10.15252/embj.201695916 |
0.8 |
|
| 2017 |
Fezai M, Slaymi C, Ben-Attia M, Kroemer G, Lang F, Jemaà M. Inhibition of Colon Carcinoma Cell Migration Following Treatment with Purified Venom from Lesser Weever Fish (Trachinus Vipera). Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 41: 2279-2288. PMID 28456793 DOI: 10.1159/000475646 |
0.72 |
|
| 2017 |
Galluzzi L, Kroemer G. Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 6: e1288334. PMID 28405522 DOI: 10.1080/2162402X.2017.1288334 |
1 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. [Autophagy, fitness and longevity]. Medecine Sciences : M/S. 33: 246-251. PMID 28367810 DOI: 10.1051/medsci/20173303010 |
1 |
|
| 2017 |
Codogno P, Kroemer G. [Be oneself eatable, in moderation, a condition to keep a healthy spirit in a healthy body]. Medecine Sciences : M/S. 33: 213-214. PMID 28367802 DOI: 10.1051/medsci/20173303002 |
0.44 |
|
| 2017 |
Vitale I, Kroemer G. Spontaneous DNA damage propels tumorigenicity. Cell Research. PMID 28361897 DOI: 10.1038/cr.2017.43 |
0.8 |
|
| 2017 |
Fend L, Rusakiewicz S, Adam J, Bastien B, Caignard A, Messaoudene M, Iribarren C, Cremer I, Marabelle A, Borg C, Semeraro M, Barraud L, Limacher JM, Eggermont A, Kroemer G, et al. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. Oncoimmunology. 6: e1163456. PMID 28197362 DOI: 10.1080/2162402X.2016.1163456 |
0.88 |
|
| 2017 |
Pietrocola F, Kroemer G. Metformin: a metabolic modulator. Oncotarget. PMID 28122334 DOI: 10.18632/oncotarget.14794 |
0.96 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Mitophagy: Permitted by Prohibitin. Current Biology : Cb. 27: R73-R76. PMID 28118594 DOI: 10.1016/j.cub.2016.11.055 |
1 |
|
| 2017 |
Eisenberg T, Abdellatif M, Zimmermann A, Schroeder S, Pendl T, Harger A, Stekovic S, Schipke J, Magnes C, Schmidt A, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, Carmona-Gutierrez D, ... ... Kroemer G, et al. Dietary spermidine for lowering high blood pressure. Autophagy. 0. PMID 28118075 DOI: 10.1080/15548627.2017.1280225 |
0.96 |
|
| 2017 |
López-Soto A, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Gonzalez S. Involvement of autophagy in NK cell development and function. Autophagy. 0. PMID 28103115 DOI: 10.1080/15548627.2016.1274486 |
1 |
|
| 2017 |
Ferrari E, Monzani R, Villella VR, Esposito S, Saluzzo F, Rossin F, D'Eletto M, Tosco A, De Gregorio F, Izzo V, Maiuri MC, Kroemer G, Raia V, Maiuri L. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation. Cell Death & Disease. 8: e2544. PMID 28079883 DOI: 10.1038/cddis.2016.476 |
0.96 |
|
| 2017 |
Izzo V, Pietrocola F, Sica V, Durand S, Lachkar S, Enot D, Bravo-San Pedro JM, Chery A, Esposito S, Raia V, Maiuri L, Maiuri MC, Kroemer G. Metabolic interactions between cysteamine and epigallocatechin gallate. Cell Cycle (Georgetown, Tex.). 0. PMID 28059601 DOI: 10.1080/15384101.2016.1249550 |
1 |
|
| 2017 |
Pietrocola F, Demont Y, Castoldi F, Enot D, Durand S, Semeraro M, Baracco EE, Pol J, Bravo-San Pedro JM, Bordenave C, Levesque S, Humeau J, Chery A, Métivier D, Madeo F, ... ... Kroemer G, et al. Metabolic effects of fasting on human and mouse blood in vivo. Autophagy. 0. PMID 28059587 DOI: 10.1080/15548627.2016.1271513 |
0.96 |
|
| 2017 |
Senovilla L, Demont Y, Humeau J, Bloy N, Kroemer G. Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells. Methods in Molecular Biology (Clifton, N.J.). 1524: 53-64. PMID 27815895 DOI: 10.1007/978-1-4939-6603-5_3 |
0.88 |
|
| 2017 |
Moya A, Larochette N, Paquet J, Deschepper M, Bensidhoum M, Izzo V, Kroemer G, Petite H, Logeart-Avramoglou D. Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia. Stem Cells (Dayton, Ohio). 35: 181-196. PMID 27578059 DOI: 10.1002/stem.2493 |
0.76 |
|
| 2016 |
Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial Cell (Graz, Austria). 3: 101-108. PMID 28357340 DOI: 10.15698/mic2016.03.483 |
1 |
|
| 2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: The complement system is also important in immunogenic cell death. Nature Reviews. Immunology. PMID 28028312 DOI: 10.1038/nri.2016.143 |
1 |
|
| 2016 |
Mondragón L, Kroemer G, Galluzzi L. Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 5: e1237328. PMID 27999755 DOI: 10.1080/2162402X.2016.1237328 |
1 |
|
| 2016 |
Kroemer G, Galluzzi L. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. PMID 27974686 DOI: 10.18632/oncotarget.13892 |
1 |
|
| 2016 |
Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annual Review of Pathology. PMID 27959630 DOI: 10.1146/annurev-pathol-052016-100247 |
1 |
|
| 2016 |
Catani JP, Medrano RF, Hunger A, Del Valle P, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology. 9: 565-574. PMID 27916291 DOI: 10.1016/j.tranon.2016.09.011 |
0.92 |
|
| 2016 |
Soussi T, Kroemer G. TP53 and 53BP1 Reunited. Trends in Cell Biology. PMID 27866833 DOI: 10.1016/j.tcb.2016.10.004 |
0.56 |
|
| 2016 |
Semeraro M, Adam J, Stoll G, Louvet E, Chaba K, Poirier-Colame V, Sauvat A, Senovilla L, Vacchelli E, Bloy N, Humeau J, Buque A, Kepp O, Zitvogel L, André F, ... ... Kroemer G, et al. The ratio of CD8(+)/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 5: e1218106. PMID 27853639 DOI: 10.1080/2162402X.2016.1218106 |
0.96 |
|
| 2016 |
Galluzzi L, Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature Reviews. Clinical Oncology. PMID 27845767 DOI: 10.1038/nrclinonc.2016.183 |
1 |
|
| 2016 |
Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, Tong M, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, ... ... Kroemer G, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nature Medicine. PMID 27841876 DOI: 10.1038/nm.4222 |
0.96 |
|
| 2016 |
Galluzzi L, Zitvogel L, Kroemer G. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research. 4: 895-902. PMID 27803050 DOI: 10.1158/2326-6066.CIR-16-0197 |
1 |
|
| 2016 |
Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/blood-2016-08-731737 |
1 |
|
| 2016 |
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790 |
1 |
|
| 2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nature Reviews. Immunology. PMID 27748397 DOI: 10.1038/nri.2016.107 |
1 |
|
| 2016 |
Wiraswati HL, Hangen E, Sanz AB, Lam NV, Reinhardt C, Sauvat A, Mogha A, Ortiz A, Kroemer G, Modjtahedi N. Apoptosis inducing factor (AIF) mediates lethal redox stress induced by menadione. Oncotarget. PMID 27738311 DOI: 10.18632/oncotarget.12562 |
0.64 |
|
| 2016 |
Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CP, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, ... ... Kroemer G, et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. PMID 27717798 DOI: 10.1016/j.immuni.2016.09.009 |
0.88 |
|
| 2016 |
Zitvogel L, Pitt JM, Daillère R, Smyth MJ, Kroemer G. Mouse models in oncoimmunology. Nature Reviews. Cancer. PMID 27687979 DOI: 10.1038/nrc.2016.91 |
0.88 |
|
| 2016 |
Galluzzi L, Kroemer G. Aberrant ketolysis fuels hepatocellular cancer progression. Cell Research. 26: 1077-1078. PMID 27644988 DOI: 10.1038/cr.2016.110 |
1 |
|
| 2016 |
Stoll G, Iribarren K, Michels J, Leary A, Zitvogel L, Cremer I, Kroemer G. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. Oncoimmunology. 5: e1177692. PMID 27622029 DOI: 10.1080/2162402X.2016.1177692 |
0.88 |
|
| 2016 |
Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, Liu P, Zhao L, Marabelle A, Zitvogel L, ... ... Kroemer G, et al. The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. PMID 27588704 DOI: 10.1038/cdd.2016.86 |
0.96 |
|
| 2016 |
Pietrocola F, Pol J, Kroemer G. Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells. Cell Cycle (Georgetown, Tex.). 15: 3327-3328. PMID 27588357 DOI: 10.1080/15384101.2016.1224797 |
0.96 |
|
| 2016 |
Missiroli S, Bonora M, Patergnani S, Poletti F, Perrone M, Gafà R, Magri E, Raimondi A, Lanza G, Tacchetti C, Kroemer G, Pandolfi PP, Pinton P, Giorgi C. PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development. Cell Reports. 16: 2415-27. PMID 27545895 DOI: 10.1016/j.celrep.2016.07.082 |
0.4 |
|
| 2016 |
Pietrocola F, Pol J, Vacchelli E, Baracco EE, Levesque S, Castoldi F, Maiuri MC, Madeo F, Kroemer G. Autophagy induction for the treatment of cancer. Autophagy. 12: 1962-1964. PMID 27532519 DOI: 10.1080/15548627.2016.1214778 |
0.96 |
|
| 2016 |
López-Otín C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 166: 802-21. PMID 27518560 DOI: 10.1016/j.cell.2016.07.031 |
1 |
|
| 2016 |
Pitt JM, Vétizou M, Waldschmitt N, Kroemer G, Chamaillard M, Boneca IG, Zitvogel L. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome. Cancer Research. PMID 27474734 DOI: 10.1158/0008-5472.CAN-16-0448 |
0.88 |
|
| 2016 |
Ladoire S, Enot D, Senovilla L, Chaix M, Zitvogel L, Kroemer G. Positive impact of autophagy in human breast cancer cells on local immunosurveillance. Oncoimmunology. 5: e1174801. PMID 27471653 DOI: 10.1080/2162402X.2016.1174801 |
0.88 |
|
| 2016 |
Ladoire S, Senovilla L, Enot D, Ghiringhelli F, Poirier-Colame V, Chaba K, Erdag G, Schaefer JT, Deacon DH, Zitvogel L, Slingluff CL, Kroemer G. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. Oncoimmunology. 5: e1160193. PMID 27471635 DOI: 10.1080/2162402X.2016.1160193 |
0.64 |
|
| 2016 |
Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674 |
1 |
|
| 2016 |
Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A, Zitvogel L, Kepp O, Kroemer G. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 5: e1149673. PMID 27471616 DOI: 10.1080/2162402X.2016.1149673 |
0.96 |
|
| 2016 |
Baracco EE, Pietrocola F, Buqué A, Bloy N, Senovilla L, Zitvogel L, Vacchelli E, Kroemer G. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 5: e1139275. PMID 27471610 DOI: 10.1080/2162402X.2016.1139275 |
0.96 |
|
| 2016 |
Kroemer G, Galluzzi L, Zitvogel L. STAT3 inhibition for cancer therapy: Cell-autonomous effects only? Oncoimmunology. 5: e1126063. PMID 27467938 DOI: 10.1080/2162402X.2015.1126063 |
1 |
|
| 2016 |
Vacchelli E, Ma Y, Baracco EE, Zitvogel L, Kroemer G. Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1. Oncoimmunology. 5: e1118600. PMID 27467929 DOI: 10.1080/2162402X.2015.1118600 |
0.92 |
|
| 2016 |
Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, Levesque S, Castoldi F, Jacquelot N, Yamazaki T, Senovilla L, Marino G, Aranda F, Durand S, Sica V, ... ... Kroemer G, et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 30: 147-60. PMID 27411589 DOI: 10.1016/j.ccell.2016.05.016 |
0.64 |
|
| 2016 |
Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, Zitvogel L. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Immunity. 44: 1255-69. PMID 27332730 DOI: 10.1016/j.immuni.2016.06.001 |
0.88 |
|
| 2016 |
Zitvogel L, Kroemer G. Unchaining NK cell-mediated anticancer immunosurveillance. Nature Immunology. 17: 746-7. PMID 27327996 DOI: 10.1038/ni.3471 |
0.88 |
|
| 2016 |
Galluzzi L, Buqué A, Kroemer G. Prevention of breast cancer by RANKL/RANK blockade. Cell Research. 26: 751-2. PMID 27325297 DOI: 10.1038/cr.2016.79 |
1 |
|
| 2016 |
Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, Eberhagen C, Rieder T, Janik D, Neff F, Straub BK, Schirmacher P, DiSpirito AA, Bandow N, Baral BS, ... ... Kroemer G, et al. Methanobactin reverses acute liver failure in a rat model of Wilson disease. The Journal of Clinical Investigation. PMID 27322060 DOI: 10.1172/JCI85226 |
0.48 |
|
| 2016 |
Modjtahedi N, Kroemer G. CHCHD4 links AIF to the biogenesis of respiratory chain complex I. Molecular & Cellular Oncology. 3: e1074332. PMID 27308594 DOI: 10.1080/23723556.2015.1074332 |
0.64 |
|
| 2016 |
Rockenfeller P, Carmona-Gutierrez D, Pietrocola F, Kroemer G, Madeo F. Ethanolamine: A novel anti-aging agent. Molecular & Cellular Oncology. 3: e1019023. PMID 27308532 DOI: 10.1080/23723556.2015.1019023 |
0.96 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nature Reviews. Neuroscience. 17: 467-84. PMID 27256553 DOI: 10.1038/nrn.2016.51 |
1 |
|
| 2016 |
Sica V, Manic G, Kroemer G, Vitale I, Galluzzi L. Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in Molecular Biology (Clifton, N.J.). 1417: 231-45. PMID 27221495 DOI: 10.1007/978-1-4939-3566-6_17 |
1 |
|
| 2016 |
Galluzzi L, Kroemer G. A four-lane highway to cancer. Nature Reviews. Molecular Cell Biology. 17: 398. PMID 27220642 DOI: 10.1038/nrm.2016.73 |
1 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Defective Autophagy Initiates Malignant Transformation. Molecular Cell. 62: 473-4. PMID 27203173 DOI: 10.1016/j.molcel.2016.05.001 |
1 |
|
| 2016 |
Vacchelli E, Enot DP, Pietrocola F, Zitvogel L, Kroemer G. Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy. Cancer Research. 76: 3122-6. PMID 27197163 DOI: 10.1158/0008-5472.CAN-16-0294 |
0.96 |
|
| 2016 |
Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in Cell Biology. 26: 655-67. PMID 27161573 DOI: 10.1016/j.tcb.2016.04.006 |
1 |
|
| 2016 |
Tortola L, Nitsch R, Bertrand MJ, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, ... ... Kroemer G, et al. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Reports. PMID 27160902 DOI: 10.1016/j.celrep.2016.04.032 |
0.64 |
|
| 2016 |
Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631 |
1 |
|
| 2016 |
Marabelle A, Routy B, Michels J, Kroemer G, Zitvogel L. Prime time for immune-checkpoint targeted therapy at ASCO 2015. Oncoimmunology. 5: e1068494. PMID 27141332 DOI: 10.1080/2162402X.2015.1068494 |
0.88 |
|
| 2016 |
Sica V, Maiuri MC, Kroemer G, Galluzzi L. Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1419: 1-16. PMID 27108427 DOI: 10.1007/978-1-4939-3581-9_1 |
1 |
|
| 2016 |
Galluzzi L, Kroemer G. Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 7: 29877-8. PMID 27105494 DOI: 10.18632/oncotarget.8841 |
1 |
|
| 2016 |
Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell. 165: 276-87. PMID 27058662 DOI: 10.1016/j.cell.2016.03.001 |
0.88 |
|
| 2016 |
Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, et al. Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 5: e1117740. PMID 27057469 DOI: 10.1080/2162402X.2015.1117740 |
1 |
|
| 2016 |
Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942 |
1 |
|
| 2016 |
Ladoire S, Enot D, Andre F, Zitvogel L, Kroemer G. Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. Oncoimmunology. 5: e1082706. PMID 27057465 DOI: 10.1080/2162402X.2015.1082706 |
0.88 |
|
| 2016 |
Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. Improvement of immunogenic chemotherapy by STAT3 inhibition. Oncoimmunology. 5: e1078061. PMID 27057456 DOI: 10.1080/2162402X.2015.1078061 |
0.96 |
|
| 2016 |
Stoll G, Zitvogel L, Kroemer G. Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis. Oncoimmunology. 5: e1067746. PMID 27057431 DOI: 10.1080/2162402X.2015.1067746 |
0.88 |
|
| 2016 |
Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G. Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells. Oncoimmunology. 5: e1064581. PMID 27057430 DOI: 10.1080/2162402X.2015.1064581 |
0.92 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kepp O, Kroemer G. Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences : Cmls. 73: 2405-10. PMID 27048813 DOI: 10.1007/s00018-016-2209-y |
1 |
|
| 2016 |
Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. The Journal of Clinical Investigation. 126: 1224-32. PMID 27035813 DOI: 10.1172/JCI81137 |
0.88 |
|
| 2016 |
Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. The Journal of Clinical Investigation. 126: 1139-43. PMID 27035805 DOI: 10.1172/JCI87316 |
0.88 |
|
| 2016 |
Zitvogel L, Rusakiewicz S, Routy B, Ayyoub M, Kroemer G. Immunological off-target effects of imatinib. Nature Reviews. Clinical Oncology. 13: 431-46. PMID 27030078 DOI: 10.1038/nrclinonc.2016.41 |
0.88 |
|
| 2016 |
Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, et al. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal For Immunotherapy of Cancer. 4: 15. PMID 26981245 DOI: 10.1186/s40425-016-0118-0 |
0.88 |
|
| 2016 |
Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier-Colame V, Chaba K, Semeraro M, Chaix M, Penault-Llorca F, Arnould L, Poillot ML, Arveux P, Delaloge S, Andre F, Zitvogel L, ... Kroemer G, et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy. 12: 864-75. PMID 26979828 DOI: 10.1080/15548627.2016.1154244 |
0.88 |
|
| 2016 |
Esposito S, Tosco A, Villella VR, Raia V, Kroemer G, Maiuri L. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. Molecular and Cellular Pediatrics. 3: 13. PMID 26976279 DOI: 10.1186/s40348-016-0040-z |
0.32 |
|
| 2016 |
Pol J, Kroemer G, Galluzzi L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 5: e1115641. PMID 26942095 DOI: 10.1080/2162402X.2015.1115641 |
1 |
|
| 2016 |
Galluzzi L, Eggermont A, Kroemer G. Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 5: e1106127. PMID 26942094 DOI: 10.1080/2162402X.2015.1106127 |
1 |
|
| 2016 |
Ma Y, Yang H, Pitt JM, Kroemer G, Zitvogel L. Therapy-induced microenvironmental changes in cancer. Journal of Molecular Medicine (Berlin, Germany). PMID 26931513 DOI: 10.1007/s00109-016-1401-8 |
0.4 |
|
| 2016 |
Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 44: 221-31. PMID 26885855 DOI: 10.1016/j.immuni.2016.01.020 |
1 |
|
| 2016 |
Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F, Yamazaki T, Poirier-Colame V, Newton A, Redouane Y, Lin YJ, Wojtkiewicz G, Iwamoto Y, Mino-Kenudson M, Huynh TG, ... ... Kroemer G, et al. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity. 44: 343-354. PMID 26872698 DOI: 10.1016/j.immuni.2015.11.024 |
0.4 |
|
| 2016 |
Jacquelot N, Enot DP, Flament C, Vimond N, Blattner C, Pitt JM, Yamazaki T, Roberti MP, Daillère R, Vétizou M, Poirier-Colame V, Semeraro M, Caignard A, Slingluff CL, Sallusto F, ... ... Kroemer G, et al. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. The Journal of Clinical Investigation. PMID 26854930 DOI: 10.1172/JCI80071 |
0.4 |
|
| 2016 |
Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C, Lupo A, Fridman WH, Dieu-Nosjean MC, Kroemer G, Sautès-Fridman C, et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Research. 76: 1746-56. PMID 26842877 DOI: 10.1158/0008-5472.CAN-15-1142 |
0.6 |
|
| 2016 |
Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Semeraro M, Jégou S, Flores C, Chen L, Kwon BS, Borg C, Weide B, Aubin F, Dalle S, Kohrt H, Ayyoub M, ... Kroemer G, et al. Immunophenotyping of stage III melanoma reveals parameters associated with patient prognosis. The Journal of Investigative Dermatology. PMID 26829031 DOI: 10.1016/j.jid.2015.12.042 |
0.88 |
|
| 2016 |
Modjtahedi N, Tokatlidis K, Dessen P, Kroemer G. Mitochondrial Proteins Containing Coiled-Coil-Helix-Coiled-Coil-Helix (CHCH) Domains in Health and Disease. Trends in Biochemical Sciences. 41: 245-60. PMID 26782138 DOI: 10.1016/j.tibs.2015.12.004 |
0.64 |
|
| 2016 |
Xie C, Ginet V, Sun Y, Koike M, Zhou K, Li T, Li H, Li Q, Wang X, Uchiyama Y, Truttmann AC, Kroemer G, Puyal J, Blomgren K, Zhu C. Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury. Autophagy. 0. PMID 26727396 DOI: 10.1080/15548627.2015.1132134 |
0.6 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in Cell Biology. 26: 1-3. PMID 26612212 DOI: 10.1016/j.tcb.2015.11.001 |
1 |
|
| 2015 |
Vitale I, Manic G, Senovilla L, Kroemer G, Galluzzi L. Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in Cancer. 1: 124-135. PMID 28741522 DOI: 10.1016/j.trecan.2015.08.001 |
1 |
|
| 2015 |
Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, Leeuwen FW, Kroemer G, et al. Modeling non-hereditary mechanisms of Alzheimer disease during apoptosis in yeast. Microbial Cell (Graz, Austria). 2: 136-138. PMID 28357285 DOI: 10.15698/mic2015.04.199 |
0.88 |
|
| 2015 |
Obrist F, Manic G, Kroemer G, Vitale I, Galluzzi L. Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology. 2: e974463. PMID 27308423 DOI: 10.4161/23723556.2014.974463 |
1 |
|
| 2015 |
Senovilla L, Kroemer G. Chemosensitization strategies for the treatment of lung cancer. Oncoscience. 2: 833-4. PMID 26682268 DOI: 10.18632/oncoscience.208 |
0.88 |
|
| 2015 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 28: 690-714. PMID 26678337 DOI: 10.1016/j.ccell.2015.10.012 |
1 |
|
| 2015 |
Jemaà M, Manic G, Lledo G, Lissa D, Reynes C, Morin N, Chibon F, Sistigu A, Castedo M, Vitale I, Kroemer G, Abrieu A. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget. PMID 26637805 DOI: 10.18632/oncotarget.6432 |
0.96 |
|
| 2015 |
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, ... ... Kroemer G, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. 6: 588. PMID 26635802 DOI: 10.3389/fimmu.2015.00588 |
0.64 |
|
| 2015 |
Galluzzi L, Kroemer G. Defective autophagy gets to the brain. Oncotarget. 6: 39396-7. PMID 26575951 DOI: 10.18632/oncotarget.6318 |
1 |
|
| 2015 |
Forveille S, Zhou H, Sauvat A, Bezu L, Müller K, Liu P, Zitvogel L, Pierron G, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle (Georgetown, Tex.). 14: 3506-12. PMID 26566869 DOI: 10.1080/15384101.2015.1093710 |
0.96 |
|
| 2015 |
Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, ... ... Kroemer G, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, N.Y.). PMID 26541610 DOI: 10.1126/science.aad1329 |
0.32 |
|
| 2015 |
Galluzzi L, Pietrocola F, Kroemer G. Molecular Regulation of Circadian Rhythms by Polyamines. Cell Metabolism. 22: 757-8. PMID 26536485 DOI: 10.1016/j.cmet.2015.10.007 |
1 |
|
| 2015 |
Bloy N, Sauvat A, Chaba K, Buqué A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 6: 41204-15. PMID 26517677 DOI: 10.18632/oncotarget.5400 |
0.96 |
|
| 2015 |
Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, ... ... Kroemer G, et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy. 11: 1878-90. PMID 26506894 DOI: 10.1080/15548627.2015.1082022 |
0.88 |
|
| 2015 |
Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673 |
1 |
|
| 2015 |
Semeraro M, Rusakiewicz S, Zitvogel L, Kroemer G. Natural killer cell mediated immunosurveillance of pediatric neuroblastoma. Oncoimmunology. 4: e1042202. PMID 26451315 DOI: 10.1080/2162402X.2015.1042202 |
0.88 |
|
| 2015 |
Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21: 1128-38. PMID 26444637 DOI: 10.1038/nm.3944 |
1 |
|
| 2015 |
Vacchelli E, Sistigu A, Yamazaki T, Vitale I, Zitvogel L, Kroemer G. Autocrine signaling of type 1 interferons in successful anticancer chemotherapy. Oncoimmunology. 4: e988042. PMID 26405588 DOI: 10.4161/2162402X.2014.988042 |
0.64 |
|
| 2015 |
Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 20: 1666-7. PMID 26400497 DOI: 10.1007/s10495-015-1154-9 |
0.68 |
|
| 2015 |
Zhou H, Forveille S, Sauvat A, Sica V, Izzo V, Durand S, Müller K, Liu P, Zitvogel L, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. Oncotarget. PMID 26378049 DOI: 10.18632/oncotarget.5613 |
0.48 |
|
| 2015 |
Piacentini M, Kroemer G. Dying to survive - apoptosis, necroptosis, autophagy as supreme experiments of nature. The International Journal of Developmental Biology. 59: 5-9. PMID 26374520 DOI: 10.1387/ijdb.150167mp |
0.64 |
|
| 2015 |
Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C, Goéré D, Mariette C, Zitvogel L, Kroemer G. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget. 6: 20840-50. PMID 26369701 DOI: 10.18632/oncotarget.4428 |
0.92 |
|
| 2015 |
Zitvogel L, Kroemer G. Subversion of anticancer immunosurveillance by radiotherapy. Nature Immunology. 16: 1005-7. PMID 26343538 DOI: 10.1038/ni.3236 |
0.88 |
|
| 2015 |
Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/fimmu.2015.00402 |
1 |
|
| 2015 |
Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G. Organelle-Specific Initiation of Autophagy. Molecular Cell. 59: 522-39. PMID 26295960 DOI: 10.1016/j.molcel.2015.07.021 |
1 |
|
| 2015 |
Gentili M, Kowal J, Tkach M, Satoh T, Lahaye X, Conrad C, Boyron M, Lombard B, Durand S, Kroemer G, Loew D, Dalod M, Théry C, Manel N. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science (New York, N.Y.). PMID 26229115 DOI: 10.1126/science.aab3628 |
0.64 |
|
| 2015 |
Zitvogel L, Kroemer G. CANCER. A p53-regulated immune checkpoint relevant to cancer. Science (New York, N.Y.). 349: 476-7. PMID 26228128 DOI: 10.1126/science.aac8475 |
0.88 |
|
| 2015 |
Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. STAT3 inhibition enhances the therapeutic efficacy of immunogenic chemotherapy by stimulating type 1 interferon production by cancer cells. Cancer Research. PMID 26208907 DOI: 10.1158/0008-5472.CAN-15-1122 |
0.64 |
|
| 2015 |
Modjtahedi N, Hangen E, Gonin P, Kroemer G. Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4. Cell Cycle (Georgetown, Tex.). 14: 2743-7. PMID 26178476 DOI: 10.1080/15384101.2015.1068477 |
0.64 |
|
| 2015 |
Kroemer G, Galluzzi L. Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 4: e1008853. PMID 26155425 DOI: 10.1080/2162402X.2015.1008853 |
1 |
|
| 2015 |
Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531 |
1 |
|
| 2015 |
Stoll G, Zitvogel L, Kroemer G. Immune infiltrate in cancer. Aging. 7: 358-9. PMID 26143478 DOI: 10.18632/aging.100770 |
0.88 |
|
| 2015 |
Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 4: e1058597. PMID 26140250 DOI: 10.1080/2162402X.2015.1058597 |
1 |
|
| 2015 |
Kroemer G, Galluzzi L. Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 4: e1058037. PMID 26140249 DOI: 10.1080/2162402X.2015.1058037 |
1 |
|
| 2015 |
Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 4: e974411. PMID 26137405 DOI: 10.4161/2162402X.2014.974411 |
1 |
|
| 2015 |
Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866 |
1 |
|
| 2015 |
Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814 |
1 |
|
| 2015 |
Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G. Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle (Georgetown, Tex.). 14: 2399-407. PMID 26098646 DOI: 10.1080/15384101.2015.1064206 |
0.48 |
|
| 2015 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Necrosis: Linking the Inflammasome to Inflammation. Cell Reports. 11: 1501-2. PMID 26082972 DOI: 10.1016/j.celrep.2015.05.041 |
1 |
|
| 2015 |
Bezu L, Gomes-da-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in Immunology. 6: 275. PMID 26082782 DOI: 10.3389/fimmu.2015.00275 |
1 |
|
| 2015 |
Stoll G, Bindea G, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget. 6: 11894-909. PMID 26059437 DOI: 10.18632/oncotarget.4180 |
0.88 |
|
| 2015 |
Maiuri L, De Stefano D, Raia V, Kroemer G. The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation. Annals of Translational Medicine. 3: S24. PMID 26046070 DOI: 10.3978/j.issn.2305-5839.2015.02.32 |
0.32 |
|
| 2015 |
Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabolism. 21: 805-21. PMID 26039447 DOI: 10.1016/j.cmet.2015.05.014 |
1 |
|
| 2015 |
Bouvier M, Chneiweiss H, Jordan B, Lagrue G, Ménard J, Teillaud JL, Kroemer G, Moulin AM, Flahault A, Lafanechère L, Maréchal É, Guillemot JC, Gaille M. The 2010 years | Les années 2010 MéDecine Sciences : M/S. 31: 91-111. PMID 26038813 DOI: 10.1051/medsci/201531s1006 |
0.64 |
|
| 2015 |
Peschanski M, Bergeron M, Boué A, Coppens Y, Changeux JP, Corvol P, Lazar P, Kahn A, Bichet DG, Friedlander G, Epelbaum J, Kroemer G, Chneiweiss H, Munnich A, Bouvier M, et al. [In Process Citation]. MéDecine Sciences : M/S. 31: 47-90. PMID 26038812 DOI: 10.1051/medsci/201531s1005 |
0.64 |
|
| 2015 |
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nature Reviews. Immunology. 15: 405-14. PMID 26027717 DOI: 10.1038/nri3845 |
1 |
|
| 2015 |
Hangen E, Féraud O, Lachkar S, Mou H, Doti N, Fimia GM, Lam NV, Zhu C, Godin I, Muller K, Chatzi A, Nuebel E, Ciccosanti F, Flamant S, Bénit P, ... ... Kroemer G, et al. Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis. Molecular Cell. 58: 1001-14. PMID 26004228 DOI: 10.1016/j.molcel.2015.04.020 |
0.64 |
|
| 2015 |
Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers in Immunology. 6: 187. PMID 25964783 DOI: 10.3389/fimmu.2015.00187 |
1 |
|
| 2015 |
Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940 |
1 |
|
| 2015 |
Zitvogel L, Kroemer G. Cancer: Antibodies regulate antitumour immunity. Nature. 521: 35-7. PMID 25924066 DOI: 10.1038/nature14388 |
0.88 |
|
| 2015 |
Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, ... ... Kroemer G, et al. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Science Translational Medicine. 7: 283ra55. PMID 25877893 DOI: 10.1126/scitranslmed.aaa2327 |
0.88 |
|
| 2015 |
Sauvat A, Wang Y, Segura F, Spaggiari S, Müller K, Zhou H, Galluzzi L, Kepp O, Kroemer G. Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 6: 9467-75. PMID 25816366 |
1 |
|
| 2015 |
Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, van Leeuwen FW, Kroemer G, et al. Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin. Cell Reports. PMID 25753421 DOI: 10.1016/j.celrep.2015.02.009 |
0.88 |
|
| 2015 |
Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. PMID 25749194 DOI: 10.1016/j.semcancer.2015.02.004 |
1 |
|
| 2015 |
Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Kroemer G, et al. Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 399-400. PMID 25732764 DOI: 10.1038/cr.2015.28 |
0.64 |
|
| 2015 |
Pedro JM, Wei Y, Sica V, Maiuri MC, Zou Z, Kroemer G, Levine B. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 11: 452-9. PMID 25715028 DOI: 10.1080/15548627.2015.1017191 |
0.64 |
|
| 2015 |
Niso-Santano M, Bravo-San Pedro JM, Maiuri MC, Tavernarakis N, Cecconi F, Madeo F, Codogno P, Galluzzi L, Kroemer G. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 11: 575-7. PMID 25714112 DOI: 10.1080/15548627.2015.1017222 |
0.64 |
|
| 2015 |
Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, ... ... Kroemer G, et al. Autophagy in malignant transformation and cancer progression. The Embo Journal. 34: 856-80. PMID 25712477 DOI: 10.15252/embj.201490784 |
0.64 |
|
| 2015 |
Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. The Journal of Clinical Investigation. 125: 85-93. PMID 25654554 DOI: 10.1172/JCI73946 |
0.96 |
|
| 2015 |
Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine. 7: 271ps1. PMID 25609166 DOI: 10.1126/scitranslmed.3010473 |
1 |
|
| 2015 |
Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mariño G, Cianfanelli V, Ben-Younès A, Troncoso R, Markaki M, Sica V, Izzo V, Chaba K, Bauvy C, Dupont N, Kepp O, ... ... Kroemer G, et al. Unsaturated fatty acids induce non-canonical autophagy. The Embo Journal. 34: 1025-41. PMID 25586377 DOI: 10.15252/embj.201489363 |
0.4 |
|
| 2015 |
Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Kroemer G, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 208-24. PMID 25582080 DOI: 10.1038/cr.2015.3 |
0.88 |
|
| 2015 |
Maiuri MC, Kroemer G. Essential role for oxidative phosphorylation in cancer progression. Cell Metabolism. 21: 11-2. PMID 25565201 DOI: 10.1016/j.cmet.2014.12.013 |
0.96 |
|
| 2014 |
Ruckenstuhl C, Netzberger C, Entfellner I, Carmona-Gutierrez D, Kickenweiz T, Stekovic S, Gleixner C, Schmid C, Klug L, Hajnal I, Sorgo AG, Eisenberg T, Büttner S, Marin O G, Koziel R, ... ... Kroemer G, et al. Autophagy extends lifespan via vacuolar acidification. Microbial Cell (Graz, Austria). 1: 160-162. PMID 28357240 DOI: 10.15698/mic2014.05.147 |
0.88 |
|
| 2014 |
Zimmermann A, Bauer MA, Kroemer G, Madeo F, Carmona-Gutierrez D. When less is more: hormesis against stress and disease. Microbial Cell (Graz, Austria). 1: 150-153. PMID 28357237 DOI: 10.15698/mic2014.05.148 |
0.88 |
|
| 2014 |
Carmona-Gutierrez D, Kroemer G, Madeo F. One cell, one love: a journal for microbial research. Microbial Cell (Graz, Austria). 1: 1-5. PMID 28357205 DOI: 10.15698/mic2014.01.118 |
0.88 |
|
| 2014 |
Aranda F, Bloy N, Galluzzi L, Kroemer G, Senovilla L. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 3: e955685. PMID 25941619 DOI: 10.4161/21624011.2014.955685 |
1 |
|
| 2014 |
Bloy N, Pol J, Manic G, Vitale I, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 3: e954929. PMID 25941606 DOI: 10.4161/21624011.2014.954929 |
1 |
|
| 2014 |
Galluzzi L, Kroemer G, Eggermont A. Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 3: e967147. PMID 25941597 DOI: 10.4161/21624011.2014.967147 |
1 |
|
| 2014 |
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424 |
1 |
|
| 2014 |
Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994 |
0.64 |
|
| 2014 |
Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology. 3: e944047. PMID 25610726 DOI: 10.4161/21624011.2014.944047 |
0.92 |
|
| 2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Kroemer G, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 |
1 |
|
| 2014 |
Zitvogel L, Kroemer G. CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance. Cancer Cell. 26: 591-3. PMID 25517740 DOI: 10.1016/j.ccell.2014.10.008 |
0.88 |
|
| 2014 |
Bonora M, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Pinton P. Novel insights into the mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 13: 2666-70. PMID 25486353 DOI: 10.4161/15384101.2014.949082 |
1 |
|
| 2014 |
Mariño G, Pietrocola F, Madeo F, Kroemer G. Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers. Autophagy. 10: 1879-82. PMID 25484097 DOI: 10.4161/auto.36413 |
0.96 |
|
| 2014 |
Büttner S, Broeskamp F, Sommer C, Markaki M, Habernig L, Alavian-Ghavanini A, Carmona-Gutierrez D, Eisenberg T, Michael E, Kroemer G, Tavernarakis N, Sigrist SJ, Madeo F. Spermidine protects against α-synuclein neurotoxicity. Cell Cycle (Georgetown, Tex.). 13: 3903-8. PMID 25483063 DOI: 10.4161/15384101.2014.973309 |
0.32 |
|
| 2014 |
Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 159: 1263-76. PMID 25480292 DOI: 10.1016/j.cell.2014.11.006 |
0.64 |
|
| 2014 |
Thepot S, Boehrer S, Seegers V, Prebet T, Beyne-Rauzy O, Wattel E, Delaunay J, Raffoux E, Hunault M, Jourdan E, Chermat F, Sebert M, Kroemer G, Fenaux P, Adès L, et al. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leukemia Research. 38: 1430-4. PMID 25449687 DOI: 10.1016/j.leukres.2014.09.014 |
0.6 |
|
| 2014 |
De Stefano D, Villella VR, Esposito S, Tosco A, Sepe A, De Gregorio F, Salvadori L, Grassia R, Leone CA, De Rosa G, Maiuri MC, Pettoello-Mantovani M, Guido S, Bossi A, Zolin A, ... ... Kroemer G, et al. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy. 10: 2053-74. PMID 25350163 DOI: 10.4161/15548627.2014.973737 |
0.96 |
|
| 2014 |
Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, ... ... Kroemer G, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nature Medicine. 20: 1301-9. PMID 25344738 DOI: 10.1038/nm.3708 |
0.32 |
|
| 2014 |
Kroemer G, Perfettini JL. Entosis, a key player in cancer cell competition. Cell Research. 24: 1280-1. PMID 25342563 DOI: 10.1038/cr.2014.133 |
0.76 |
|
| 2014 |
Zitvogel L, Kroemer G. Cytokines reinstate NK cell-mediated cancer immunosurveillance. The Journal of Clinical Investigation. 124: 4687-9. PMID 25329691 DOI: 10.1172/JCI78531 |
0.88 |
|
| 2014 |
Zitvogel L, Kroemer G. Targeting foxp1 for reinstating anticancer immunosurveillance. Immunity. 41: 345-7. PMID 25238089 DOI: 10.1016/j.immuni.2014.09.001 |
0.88 |
|
| 2014 |
Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 345: 1250256. PMID 25237106 DOI: 10.1126/science.1250256 |
1 |
|
| 2014 |
Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Caloric restriction mimetics: towards a molecular definition. Nature Reviews. Drug Discovery. 13: 727-40. PMID 25212602 DOI: 10.1038/nrd4391 |
0.96 |
|
| 2014 |
Michels J, Obrist F, Castedo M, Vitale I, Kroemer G. PARP and other prospective targets for poisoning cancer cell metabolism. Biochemical Pharmacology. 92: 164-71. PMID 25199458 DOI: 10.1016/j.bcp.2014.08.026 |
0.96 |
|
| 2014 |
Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget. 5: 5190-1. PMID 25114034 DOI: 10.18632/oncotarget.2266 |
0.96 |
|
| 2014 |
Michels J, Obrist F, Vitale I, Lissa D, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Castedo M, Kroemer G. MCL-1 dependency of cisplatin-resistant cancer cells. Biochemical Pharmacology. 92: 55-61. PMID 25107702 DOI: 10.1016/j.bcp.2014.07.029 |
0.64 |
|
| 2014 |
Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/onci.28694 |
1 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/onci.29179 |
1 |
|
| 2014 |
Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/onci.29030 |
1 |
|
| 2014 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nature Cell Biology. 16: 728-36. PMID 25082195 DOI: 10.1038/ncb3005 |
1 |
|
| 2014 |
Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 3: e28473. PMID 25050214 DOI: 10.4161/onci.28473 |
1 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344 |
1 |
|
| 2014 |
Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O, Kroemer G. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology. 3: e28276. PMID 25050202 DOI: 10.4161/onci.28276 |
0.96 |
|
| 2014 |
Schroeder S, Pendl T, Zimmermann A, Eisenberg T, Carmona-Gutierrez D, Ruckenstuhl C, Mariño G, Pietrocola F, Harger A, Magnes C, Sinner F, Pieber TR, Dengjel J, Sigrist SJ, Kroemer G, et al. Acetyl-coenzyme A: a metabolic master regulator of autophagy and longevity. Autophagy. 10: 1335-7. PMID 24904996 DOI: 10.4161/auto.28919 |
0.32 |
|
| 2014 |
Eisenberg T, Schroeder S, Büttner S, Carmona-Gutierrez D, Pendl T, Andryushkova A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Magnes C, Sinner F, Sedej S, Pieber TR, Dengjel J, ... ... Kroemer G, et al. A histone point mutation that switches on autophagy. Autophagy. 10: 1143-5. PMID 24879160 DOI: 10.4161/auto.28767 |
0.32 |
|
| 2014 |
Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 3: e27878. PMID 24800173 DOI: 10.4161/onci.27878 |
1 |
|
| 2014 |
Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G. Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology. 3: e27663. PMID 24800170 DOI: 10.4161/onci.27663 |
1 |
|
| 2014 |
Pietrocola F, Malik SA, Mariño G, Vacchelli E, Senovilla L, Chaba K, Niso-Santano M, Maiuri MC, Madeo F, Kroemer G. Coffee induces autophagy in vivo. Cell Cycle (Georgetown, Tex.). 13: 1987-94. PMID 24769862 DOI: 10.4161/cc.28929 |
0.96 |
|
| 2014 |
Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27297. PMID 24701370 DOI: 10.4161/onci.27297 |
1 |
|
| 2014 |
Mariño G, Pietrocola F, Kong Y, Eisenberg T, Hill JA, Madeo F, Kroemer G. Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. Autophagy. 10: 930-2. PMID 24675140 DOI: 10.4161/auto.28235 |
0.96 |
|
| 2014 |
Eisenberg T, Schroeder S, Andryushkova A, Pendl T, Küttner V, Bhukel A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Moustafa T, Sprenger A, Jany E, Büttner S, Carmona-Gutierrez D, ... ... Kroemer G, et al. Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespan. Cell Metabolism. 19: 431-44. PMID 24606900 DOI: 10.1016/j.cmet.2014.02.010 |
0.32 |
|
| 2014 |
Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27048. PMID 24605265 DOI: 10.4161/onci.27048 |
1 |
|
| 2014 |
Mariño G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, Zamzami N, Scoazec M, Durand S, Enot DP, Fernández ÁF, ... ... Kroemer G, et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Molecular Cell. 53: 710-25. PMID 24560926 DOI: 10.1016/j.molcel.2014.01.016 |
1 |
|
| 2014 |
Lissa D, Senovilla L, Rello-Varona S, Vitale I, Michaud M, Pietrocola F, Boilève A, Obrist F, Bordenave C, Garcia P, Michels J, Jemaà M, Kepp O, Castedo M, Kroemer G. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention. Proceedings of the National Academy of Sciences of the United States of America. 111: 3020-5. PMID 24516128 DOI: 10.1073/pnas.1318440111 |
0.96 |
|
| 2014 |
Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, ... ... Kroemer G, et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Research. 74: 436-45. PMID 24302580 DOI: 10.1158/0008-5472.CAN-13-1265 |
1 |
|
| 2013 |
Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2: e26621. PMID 24498550 DOI: 10.4161/onci.26621 |
1 |
|
| 2013 |
Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2: e26494. PMID 24482747 DOI: 10.4161/onci.26494 |
1 |
|
| 2013 |
Vacchelli E, Vitale I, Tartour E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology. 2: e25595. PMID 24319634 DOI: 10.4161/onci.25595 |
1 |
|
| 2013 |
Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 9: 1624-5. PMID 23989612 DOI: 10.4161/auto.25873 |
1 |
|
| 2013 |
Lainey E, Wolfromm A, Sukkurwala AQ, Micol JB, Fenaux P, Galluzzi L, Kepp O, Kroemer G. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex.). 12: 2978-91. PMID 23974111 DOI: 10.4161/cc.26016 |
1 |
|
| 2013 |
Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G. Antiapoptotic activity of argon and xenon. Cell Cycle (Georgetown, Tex.). 12: 2636-42. PMID 23907115 DOI: 10.4161/cc.25650 |
1 |
|
| 2013 |
Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology. 2: e24568. PMID 23894718 DOI: 10.4161/onci.24568 |
1 |
|
| 2013 |
Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L. Crosstalk between ER stress and immunogenic cell death. Cytokine & Growth Factor Reviews. 24: 311-8. PMID 23787159 DOI: 10.1016/j.cytogfr.2013.05.001 |
1 |
|
| 2013 |
Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G. Fluorescent biosensors for the detection of HMGB1 release. Methods in Molecular Biology (Clifton, N.J.). 1004: 43-56. PMID 23733568 DOI: 10.1007/978-1-62703-383-1_4 |
1 |
|
| 2013 |
Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Regulation of autophagy by stress-responsive transcription factors. Seminars in Cancer Biology. 23: 310-22. PMID 23726895 DOI: 10.1016/j.semcancer.2013.05.008 |
1 |
|
| 2013 |
Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, ... ... Kroemer G, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 38: 729-41. PMID 23562161 DOI: 10.1016/j.immuni.2013.03.003 |
0.4 |
|
| 2013 |
Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, ... ... Kroemer G, et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Research. 73: 2271-80. PMID 23554447 DOI: 10.1158/0008-5472.CAN-12-3000 |
1 |
|
| 2013 |
Michels J, Kepp O, Senovilla L, Lissa D, Castedo M, Kroemer G, Galluzzi L. Functions of BCL-X L at the Interface between Cell Death and Metabolism. International Journal of Cell Biology. 2013: 705294. PMID 23533418 DOI: 10.1155/2013/705294 |
1 |
|
| 2013 |
Michels J, Vitale I, Senovilla L, Enot DP, Garcia P, Lissa D, Olaussen KA, Brenner C, Soria JC, Castedo M, Kroemer G. Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer. Cell Cycle (Georgetown, Tex.). 12: 877-83. PMID 23428903 DOI: 10.4161/cc.24034 |
0.64 |
|
| 2013 |
Galluzzi L, Goubar A, Olaussen KA, Vitale I, Senovilla L, Michels J, Robin A, Dorvault N, Besse B, Validire P, Fouret P, Behrens C, Wistuba II, Soria JC, Kroemer G. Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle (Georgetown, Tex.). 12: 647-54. PMID 23343765 DOI: 10.4161/cc.23517 |
1 |
|
| 2013 |
Boilève A, Senovilla L, Vitale I, Lissa D, Martins I, Métivier D, van den Brink S, Clevers H, Galluzzi L, Castedo M, Kroemer G. Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell Cycle (Georgetown, Tex.). 12: 473-9. PMID 23324343 DOI: 10.4161/cc.23369 |
1 |
|
| 2013 |
Kepp O, Martins I, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Galluzzi L, Kroemer G. Quantification of cell cycle-arresting proteins. Methods in Molecular Biology (Clifton, N.J.). 965: 121-42. PMID 23296654 DOI: 10.1007/978-1-62703-239-1_7 |
1 |
|
| 2013 |
Vitale I, Jemaà M, Galluzzi L, Metivier D, Castedo M, Kroemer G. Cytofluorometric assessment of cell cycle progression. Methods in Molecular Biology (Clifton, N.J.). 965: 93-120. PMID 23296653 DOI: 10.1007/978-1-62703-239-1_6 |
1 |
|
| 2013 |
Galluzzi L, Marsili S, Vitale I, Senovilla L, Michels J, Garcia P, Vacchelli E, Chatelut E, Castedo M, Kroemer G. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell Cycle (Georgetown, Tex.). 12: 417-21. PMID 23287530 DOI: 10.4161/cc.23275 |
1 |
|
| 2013 |
Jemaà M, Galluzzi L, Kepp O, Castedo M, Rello-Varona S, Vitale I, Kroemer G. Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations. Cell Cycle (Georgetown, Tex.). 12: 183-90. PMID 23255111 DOI: 10.4161/cc.23046 |
1 |
|
| 2013 |
Niso-Santano M, Shen S, Adjemian S, Malik SA, Mariño G, Lachkar S, Senovilla L, Kepp O, Galluzzi L, Maiuri MC, Kroemer G. Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy. Autophagy. 9: 415-7. PMID 23221979 DOI: 10.4161/auto.22910 |
1 |
|
| 2012 |
Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G. Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 1: 1640-1642. PMID 23264921 DOI: 10.4161/onci.21684 |
1 |
|
| 2012 |
Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 1: 1323-1343. PMID 23243596 DOI: 10.4161/onci.22009 |
1 |
|
| 2012 |
Lainey E, Sébert M, Thépot S, Scoazec M, Bouteloup C, Leroy C, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 11: 4079-92. PMID 23095522 DOI: 10.4161/cc.22382 |
1 |
|
| 2012 |
Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Mariño G, Lachkar S, Senovilla L, Galluzzi L, Kepp O, Pierron G, Maiuri MC, Hikita H, ... ... Kroemer G, et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Molecular Cell. 48: 667-80. PMID 23084476 DOI: 10.1016/j.molcel.2012.09.013 |
1 |
|
| 2012 |
Pietrocola F, Mariño G, Lissa D, Vacchelli E, Malik SA, Niso-Santano M, Zamzami N, Galluzzi L, Maiuri MC, Kroemer G. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle (Georgetown, Tex.). 11: 3851-60. PMID 23070521 DOI: 10.4161/cc.22027 |
1 |
|
| 2012 |
Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, ... ... Kroemer G, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 337: 1678-84. PMID 23019653 DOI: 10.1126/science.1224922 |
0.32 |
|
| 2012 |
Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Kroemer G, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 |
0.64 |
|
| 2012 |
Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, ... ... Kroemer G, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Reports. 2: 257-69. PMID 22854025 DOI: 10.1016/j.celrep.2012.06.017 |
1 |
|
| 2012 |
Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, ... ... Kroemer G, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science Translational Medicine. 4: 143ra99. PMID 22814852 DOI: 10.1126/scitranslmed.3003807 |
1 |
|
| 2012 |
Michaud M, Sukkurwala AQ, Martins I, Shen S, Zitvogel L, Kroemer G. Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39. Oncoimmunology. 1: 393-395. PMID 22737627 DOI: 10.4161/onci.19070 |
0.92 |
|
| 2012 |
Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, ... ... Kroemer G, et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 1: 271-278. PMID 22737602 DOI: 10.4161/onci.18684 |
0.64 |
|
| 2012 |
Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, Rosenfeldt M, Ryan KM, Zitvogel L, Kroemer G. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy. 8: 1175-84. PMID 22647537 DOI: 10.4161/auto.20353 |
1 |
|
| 2012 |
Jemaà M, Galluzzi L, Kepp O, Boilève A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A, Castedo M, Vitale I, Kroemer G. Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle (Georgetown, Tex.). 11: 2149-58. PMID 22592527 DOI: 10.4161/cc.20621 |
1 |
|
| 2012 |
Bennetzen MV, Mariño G, Pultz D, Morselli E, Færgeman NJ, Kroemer G, Andersen JS. Phosphoproteomic analysis of cells treated with longevity-related autophagy inducers. Cell Cycle (Georgetown, Tex.). 11: 1827-40. PMID 22517431 DOI: 10.4161/cc.20233 |
0.96 |
|
| 2012 |
Jemaà M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, Mariño G, Malik SA, Rello-Varona S, Lissa D, Antoccia A, Tailler M, Schlemmer F, Harper F, Pierron G, ... ... Kroemer G, et al. Selective killing of p53-deficient cancer cells by SP600125. Embo Molecular Medicine. 4: 500-14. PMID 22438244 DOI: 10.1002/emmm.201200228 |
1 |
|
| 2012 |
Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 8: 413-5. PMID 22361584 DOI: 10.4161/auto.19009 |
1 |
|
| 2012 |
Niso-Santano M, Criollo A, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Galluzzi L, Maiuri MC, Kroemer G. Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway. Autophagy. 8: 268-70. PMID 22301997 DOI: 10.4161/auto.8.2.18845 |
1 |
|
| 2012 |
Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Autophagy is required for the activation of NFκB. Cell Cycle (Georgetown, Tex.). 11: 194-9. PMID 22186785 DOI: 10.4161/cc.11.1.18669 |
1 |
|
| 2012 |
Rello-Varona S, Lissa D, Shen S, Niso-Santano M, Senovilla L, Mariño G, Vitale I, Jemaá M, Harper F, Pierron G, Castedo M, Kroemer G. Autophagic removal of micronuclei. Cell Cycle (Georgetown, Tex.). 11: 170-6. PMID 22185757 DOI: 10.4161/cc.11.1.18564 |
0.96 |
|
| 2012 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Younes AB, Maiuri MC, Kroemer G. Evaluation of rapamycin-induced cell death. Methods in Molecular Biology (Clifton, N.J.). 821: 125-69. PMID 22125064 DOI: 10.1007/978-1-61779-430-8_9 |
1 |
|
| 2011 |
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, ... ... Kroemer G, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (New York, N.Y.). 334: 1573-7. PMID 22174255 DOI: 10.1126/science.1208347 |
1 |
|
| 2011 |
Criollo A, Niso-Santano M, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Arkhipenko AV, Harper F, Pierron G, Rain JC, Ninomiya-Tsuji J, Fuentes JM, Lavandero S, Galluzzi L, ... ... Kroemer G, et al. Inhibition of autophagy by TAB2 and TAB3. The Embo Journal. 30: 4908-20. PMID 22081109 DOI: 10.1038/emboj.2011.413 |
1 |
|
| 2011 |
Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Adès L, Thépot S, Sébert M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 3168-75. PMID 21897118 DOI: 10.4161/cc.10.18.16599 |
1 |
|
| 2011 |
Boehrer S, Lainey E, Kroemer G. Coordinated epigenetic regulation of autophagy and apoptosis. Cell Cycle (Georgetown, Tex.). 10: 2832-3. PMID 21869599 |
0.6 |
|
| 2011 |
Malik SA, Mariño G, BenYounès A, Shen S, Harper F, Maiuri MC, Kroemer G. Neuroendocrine regulation of autophagy by leptin. Cell Cycle (Georgetown, Tex.). 10: 2917-23. PMID 21857156 DOI: 10.4161/cc.10.17.17067 |
0.96 |
|
| 2011 |
Morselli E, Shen S, Ruckenstuhl C, Bauer MA, Mariño G, Galluzzi L, Criollo A, Michaud M, Maiuri MC, Chano T, Madeo F, Kroemer G. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle (Georgetown, Tex.). 10: 2763-9. PMID 21775823 DOI: 10.4161/cc.10.16.16868 |
0.64 |
|
| 2011 |
Castedo M, Galluzzi L, Vitale I, Senovilla L, Métivier D, Jèmaà M, Rello-Varona S, Kroemer G. Cytofluorometric purification of diploid and tetraploid cancer cells. Methods in Molecular Biology (Clifton, N.J.). 761: 47-63. PMID 21755440 DOI: 10.1007/978-1-61779-182-6_3 |
1 |
|
| 2011 |
Lainey E, Thépot S, Bouteloup C, Sébert M, Adès L, Tailler M, Gardin C, de Botton S, Baruchel A, Fenaux P, Kroemer G, Boehrer S. Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action. Biochemical Pharmacology. 82: 1457-66. PMID 21664897 DOI: 10.1016/j.bcp.2011.05.011 |
0.6 |
|
| 2011 |
Thépot S, Lainey E, Cluzeau T, Sébert M, Leroy C, Adès L, Tailler M, Galluzzi L, Baran-Marszak F, Roudot H, Eclache V, Gardin C, de Botton S, Auberger P, Fenaux P, ... Kroemer G, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 2323-30. PMID 21654193 DOI: 10.4161/cc.10.14.16399 |
1 |
|
| 2011 |
Malik SA, Shen S, Mariño G, BenYounès A, Maiuri MC, Kroemer G. BH3 mimetics reveal the network properties of autophagy-regulatory signaling cascades. Autophagy. 7: 914-6. PMID 21508685 |
0.96 |
|
| 2011 |
Mariño G, Morselli E, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, ... ... Kroemer G, et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy. 7: 647-9. PMID 21460620 DOI: 10.4161/auto.7.6.15191 |
0.64 |
|
| 2011 |
BenYounès A, Tajeddine N, Tailler M, Malik SA, Shen S, Métivier D, Kepp O, Vitale I, Maiuri MC, Kroemer G. A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1. Autophagy. 7: 883-91. PMID 21460612 |
0.96 |
|
| 2011 |
Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, ... ... Kroemer G, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. The Journal of Experimental Medicine. 208: 491-503. PMID 21383056 DOI: 10.1084/jem.20100269 |
0.88 |
|
| 2011 |
Morselli E, Mariño G, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, ... ... Kroemer G, et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. The Journal of Cell Biology. 192: 615-29. PMID 21339330 DOI: 10.1083/jcb.201008167 |
0.64 |
|
| 2011 |
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Reviews. 30: 61-9. PMID 21249425 DOI: 10.1007/s10555-011-9273-4 |
1 |
|
| 2011 |
Zoubir M, Flament C, Gdoura A, Bahleda R, Litvinova E, Soumelis V, Conforti R, Viaud S, Soria JC, Kroemer G, Zitvogel L, Chaput N. An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpesviridae. Cell Cycle (Georgetown, Tex.). 10: 118-26. PMID 21200142 DOI: 10.4161/cc.10.1.14445 |
0.88 |
|
| 2011 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Pinti M, Kroemer G. Mitochondrial liaisons of p53. Antioxidants & Redox Signaling. 15: 1691-714. PMID 20712408 DOI: 10.1089/ars.2010.3504 |
1 |
|
| 2011 |
Morselli E, Galluzzi L, Kepp O, Mariño G, Michaud M, Vitale I, Maiuri MC, Kroemer G. Oncosuppressive functions of autophagy. Antioxidants & Redox Signaling. 14: 2251-69. PMID 20712403 DOI: 10.1089/ars.2010.3478 |
1 |
|
| 2010 |
Locher C, Conforti R, Aymeric L, Ma Y, Yamazaki T, Rusakiewicz S, Tesnière A, Ghiringhelli F, Apetoh L, Morel Y, Girard JP, Kroemer G, Zitvogel L. Desirable cell death during anticancer chemotherapy. Annals of the New York Academy of Sciences. 1209: 99-108. PMID 20958322 DOI: 10.1111/j.1749-6632.2010.05763.x |
0.64 |
|
| 2010 |
Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G. Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Annals of the New York Academy of Sciences. 1209: 77-82. PMID 20958319 DOI: 10.1111/j.1749-6632.2010.05740.x |
1 |
|
| 2010 |
Kepp O, Gdoura A, Martins I, Panaretakis T, Schlemmer F, Tesniere A, Fimia GM, Ciccosanti F, Burgevin A, Piacentini M, Eggleton P, Young PJ, Zitvogel L, van Endert P, Kroemer G. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death. Cell Cycle (Georgetown, Tex.). 9: 3072-7. PMID 20699648 DOI: 10.4161/cc.9.15.12459 |
0.64 |
|
| 2010 |
Vitale I, Jemaà M, Senovilla L, Galluzzi L, Rello-Varona S, Metivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G. Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell Cycle (Georgetown, Tex.). 9: 2823-9. PMID 20686359 |
1 |
|
| 2010 |
Tesniere A, Abermil N, Schlemmer F, Casares N, Kepp O, Pequignot M, Michaud M, Martins I, Senovilla L, Zitvogel L, Kroemer G. In vivo depletion of T lymphocyte-specific transcription factors by RNA interference. Cell Cycle (Georgetown, Tex.). 9: 2830-5. PMID 20647758 |
0.96 |
|
| 2010 |
Ma Y, Kepp O, Ghiringhelli F, Apetoh L, Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L. Chemotherapy and radiotherapy: cryptic anticancer vaccines. Seminars in Immunology. 22: 113-24. PMID 20403709 DOI: 10.1016/j.smim.2010.03.001 |
0.64 |
|
| 2010 |
Vitale I, Senovilla L, Jemaà M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, Métivier D, Vivet S, Tajeddine N, Joza N, Valent A, ... ... Kroemer G, et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. The Embo Journal. 29: 1272-84. PMID 20186124 DOI: 10.1038/emboj.2010.11 |
1 |
|
| 2010 |
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, ... Kroemer G, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Research. 70: 1793-803. PMID 20145152 DOI: 10.1158/0008-5472.CAN-09-3112 |
1 |
|
| 2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, ... ... Kroemer G, et al. IKK connects autophagy to major stress pathways. Autophagy. 6: 189-91. PMID 20110771 |
1 |
|
| 2010 |
Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, Kroemer G, Smyth MJ, Zitvogel L. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Research. 70: 855-8. PMID 20086177 DOI: 10.1158/0008-5472.CAN-09-3566 |
0.92 |
|
| 2010 |
Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Current Opinion in Cell Biology. 22: 181-5. PMID 20044243 DOI: 10.1016/j.ceb.2009.12.001 |
1 |
|
| 2010 |
Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy. 6: 186-8. PMID 20023410 DOI: 10.4161/auto.6.1.10817 |
0.64 |
|
| 2010 |
Galluzzi L, Morselli E, Kepp O, Maiuri MC, Kroemer G. Defective autophagy control by the p53 rheostat in cancer. Cell Cycle (Georgetown, Tex.). 9: 250-5. PMID 20023384 DOI: 10.4161/cc.9.2.10493 |
1 |
|
| 2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, ... ... Kroemer G, et al. The IKK complex contributes to the induction of autophagy. The Embo Journal. 29: 619-31. PMID 19959994 DOI: 10.1038/emboj.2009.364 |
1 |
|
| 2010 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Mitochondrial gateways to cancer. Molecular Aspects of Medicine. 31: 1-20. PMID 19698742 DOI: 10.1016/j.mam.2009.08.002 |
1 |
|
| 2009 |
Tesniere A, Kroemer G, Tursz T, Zitvogel L. Personalized immunotherapy: a siren myth? Personalized Medicine. 6: 469-473. PMID 29783309 DOI: 10.2217/pme.09.39 |
0.88 |
|
| 2009 |
Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, Madeo F, Kroemer G. Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging. 1: 961-70. PMID 20157579 |
0.64 |
|
| 2009 |
Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle (Georgetown, Tex.). 8: 3971-7. PMID 19901557 DOI: 10.4161/cc.8.23.10191 |
1 |
|
| 2009 |
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettini JL, Zitvogel L, Kroemer G. Chemotherapy induces ATP release from tumor cells. Cell Cycle (Georgetown, Tex.). 8: 3723-8. PMID 19855167 DOI: 10.4161/cc.8.22.10026 |
0.96 |
|
| 2009 |
Locher C, Rusakiewicz S, Tesnière A, Ghiringhelli F, Apetoh L, Kroemer G, Zitvogel L. Witch hunt against tumor cells enhanced by dendritic cells. Annals of the New York Academy of Sciences. 1174: 51-60. PMID 19769736 DOI: 10.1111/j.1749-6632.2009.04940.x |
0.88 |
|
| 2009 |
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, ... ... Kroemer G, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1Β-dependent adaptive immunity against tumors Nature Medicine. 15: 1170-1178. PMID 19767732 DOI: 10.1038/nm.2028 |
0.64 |
|
| 2009 |
Morselli E, Galluzzi L, Kepp O, Kroemer G. Nutlin kills cancer cells via mitochondrial p53. Cell Cycle (Georgetown, Tex.). 8: 1647-8. PMID 19448434 |
1 |
|
| 2009 |
Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL, Carnuccio R, Kroemer G. Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle (Georgetown, Tex.). 8: 1571-6. PMID 19377293 DOI: 10.4161/cc.8.10.8498 |
0.96 |
|
| 2009 |
Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. Anti- and pro-tumor functions of autophagy. Biochimica Et Biophysica Acta. 1793: 1524-32. PMID 19371598 DOI: 10.1016/j.bbamcr.2009.01.006 |
1 |
|
| 2009 |
Rello-Varona S, Vitale I, Kepp O, Senovilla L, Jemaá M, Métivier D, Castedo M, Kroemer G. Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5. Cell Cycle (Georgetown, Tex.). 8: 1030-5. PMID 19270519 DOI: 10.4161/cc.8.7.7950 |
0.96 |
|
| 2009 |
Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G. Viral subversion of immunogenic cell death. Cell Cycle (Georgetown, Tex.). 8: 860-9. PMID 19221507 DOI: 10.4161/cc.8.6.7939 |
1 |
|
| 2009 |
Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, Yuan J, Zitvogel L, Madeo F, Williams DB, Kroemer G. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. The Embo Journal. 28: 578-90. PMID 19165151 DOI: 10.1038/emboj.2009.1 |
0.64 |
|
| 2009 |
Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis : An International Journal On Programmed Cell Death. 14: 364-75. PMID 19145485 DOI: 10.1007/s10495-008-0303-9 |
0.96 |
|
| 2009 |
Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Current Opinion in Oncology. 21: 71-6. PMID 19125021 DOI: 10.1097/CCO.0b013e32831bc375 |
0.96 |
|
| 2009 |
Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochimica Et Biophysica Acta. 1787: 402-13. PMID 18848916 DOI: 10.1016/j.bbabio.2008.09.006 |
1 |
|
| 2008 |
Zitvogel L, Tesniere A, Apetoh L, Ghiringhelli F, Kroemer G. [Immunological aspects of anticancer chemotherapy]. Bulletin De L'Academie Nationale De Medecine. 192: 1469-87; discussion . PMID 19445369 |
0.88 |
|
| 2008 |
Tasdemir E, Maiuri MC, Orhon I, Kepp O, Morselli E, Criollo A, Kroemer G. p53 represses autophagy in a cell cycle-dependent fashion. Cell Cycle (Georgetown, Tex.). 7: 3006-11. PMID 18838865 DOI: 10.4161/cc.7.19.6702 |
0.96 |
|
| 2008 |
Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle (Georgetown, Tex.). 7: 3056-61. PMID 18818522 DOI: 10.4161/cc.7.19.6751 |
1 |
|
| 2008 |
Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, Kroemer G. Life, death and burial: multifaceted impact of autophagy. Biochemical Society Transactions. 36: 786-90. PMID 18793137 DOI: 10.1042/BST0360786 |
1 |
|
| 2008 |
Tavernarakis N, Pasparaki A, Tasdemir E, Maiuri MC, Kroemer G. The effects of p53 on whole organism longevity are mediated by autophagy. Autophagy. 4: 870-3. PMID 18728385 |
0.64 |
|
| 2008 |
Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 13: 1148-61. PMID 18670883 DOI: 10.1007/s10495-008-0243-4 |
0.68 |
|
| 2008 |
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Targeting p53 to mitochondria for cancer therapy. Cell Cycle (Georgetown, Tex.). 7: 1949-55. PMID 18642442 DOI: 10.4161/cc.7.13.6222 |
1 |
|
| 2008 |
Fabre C, Grosjean J, Tailler M, Boehrer S, Adès L, Perfettini JL, de Botton S, Fenaux P, Kroemer G. A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. Cell Cycle (Georgetown, Tex.). 7: 2139-45. PMID 18641459 DOI: 10.4161/cc.7.14.6268 |
0.76 |
|
| 2008 |
Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. Biochemical Pharmacology. 76: 1417-25. PMID 18617157 DOI: 10.1016/j.bcp.2008.05.024 |
1 |
|
| 2008 |
Tasdemir E, Chiara Maiuri M, Morselli E, Criollo A, D'Amelio M, Djavaheri-Mergny M, Cecconi F, Tavernarakis N, Kroemer G. A dual role of p53 in the control of autophagy. Autophagy. 4: 810-4. PMID 18604159 |
0.64 |
|
| 2008 |
Morselli E, Galluzzi L, Kroemer G. Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell Research. 18: 708-10. PMID 18596700 DOI: 10.1038/cr.2008.77 |
1 |
|
| 2008 |
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Immunogenic cancer cell death: a key-lock paradigm. Current Opinion in Immunology. 20: 504-11. PMID 18573340 DOI: 10.1016/j.coi.2008.05.007 |
0.96 |
|
| 2008 |
Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success? The Journal of Clinical Investigation. 118: 1991-2001. PMID 18523649 DOI: 10.1172/JCI35180 |
0.88 |
|
| 2008 |
Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Research. 68: 4026-30. PMID 18519658 DOI: 10.1158/0008-5472.CAN-08-0427 |
0.88 |
|
| 2008 |
Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. Plos Pathogens. 4: e1000018. PMID 18516228 DOI: 10.1371/journal.ppat.1000018 |
1 |
|
| 2008 |
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R, ... ... Kroemer G, et al. Regulation of autophagy by cytoplasmic p53. Nature Cell Biology. 10: 676-87. PMID 18454141 DOI: 10.1038/ncb1730 |
0.64 |
|
| 2008 |
Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, Morselli E, Ben Younes A, Maiuri MC, Lavandero S, Kroemer G. Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology. 54: 92-9. PMID 18451641 DOI: 10.1159/000129697 |
1 |
|
| 2008 |
Tasdemir E, Galluzzi L, Maiuri MC, Criollo A, Vitale I, Hangen E, Modjtahedi N, Kroemer G. Methods for assessing autophagy and autophagic cell death. Methods in Molecular Biology (Clifton, N.J.). 445: 29-76. PMID 18425442 DOI: 10.1007/978-1-59745-157-4_3 |
1 |
|
| 2008 |
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. To die or not to die: that is the autophagic question. Current Molecular Medicine. 8: 78-91. PMID 18336289 |
1 |
|
| 2008 |
Boehrer S, Adès L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood. 111: 2170-80. PMID 17925489 DOI: 10.1182/blood-2007-07-100362 |
1 |
|
| 2007 |
Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S, Pauleau AL, Rosselli F, D'Amelio M, Amendola R, Castedo M, Hengartner M, Soria JC, Cecconi F, Kroemer G. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Molecular Cell. 28: 624-37. PMID 18042457 DOI: 10.1016/j.molcel.2007.09.030 |
0.64 |
|
| 2007 |
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, André F, Tursz T, Kroemer G, Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews. 220: 47-59. PMID 17979839 DOI: 10.1111/j.1600-065X.2007.00573.x |
0.88 |
|
| 2007 |
Obeid M, Tesniere A, Panaretakis T, Tufi R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N, Flament C, Ullrich E, de Botton S, Zitvogel L, Kroemer G. Ecto-calreticulin in immunogenic chemotherapy. Immunological Reviews. 220: 22-34. PMID 17979837 DOI: 10.1111/j.1600-065X.2007.00567.x |
0.88 |
|
| 2007 |
Chaput N, De Botton S, Obeid M, Apetoh L, Ghiringhelli F, Panaretakis T, Flament C, Zitvogel L, Kroemer G. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference. Journal of Molecular Medicine (Berlin, Germany). 85: 1069-76. PMID 17891368 DOI: 10.1007/s00109-007-0214-1 |
0.88 |
|
| 2007 |
Tasdemir E, Maiuri MC, Tajeddine N, Vitale I, Criollo A, Vicencio JM, Hickman JA, Geneste O, Kroemer G. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle (Georgetown, Tex.). 6: 2263-7. PMID 17890908 DOI: 10.4161/cc.6.18.4681 |
0.96 |
|
| 2007 |
Apetoh L, Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Piacentini M, Kroemer G, Zitvogel L. Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells. Cancer Genomics & Proteomics. 4: 65-70. PMID 17804868 |
0.64 |
|
| 2007 |
Obeid M, Panaretakis T, Tesniere A, Joza N, Tufi R, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Research. 67: 7941-4. PMID 17804698 DOI: 10.1158/0008-5472.CAN-07-1622 |
0.88 |
|
| 2007 |
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, ... ... Kroemer G, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine. 13: 1050-9. PMID 17704786 DOI: 10.1038/nm1622 |
0.96 |
|
| 2007 |
de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, Ripoche H, Lazar V, Dessen P, Harper F, Pierron G, Pinna G, Araujo N, Harel-Belan A, Armand JP, ... ... Kroemer G, et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Research. 67: 6253-62. PMID 17616683 DOI: 10.1158/0008-5472.CAN-07-0538 |
1 |
|
| 2007 |
Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K, Tavernarakis N, Hickman JA, Geneste O, Kroemer G. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. The Embo Journal. 26: 2527-39. PMID 17446862 DOI: 10.1038/sj.emboj.7601689 |
0.64 |
|
| 2007 |
Zamzami N, Maisse C, Métivier D, Kroemer G. Measurement of membrane permeability and the permeability transition of mitochondria. Methods in Cell Biology. 80: 327-40. PMID 17445702 DOI: 10.1016/S0091-679X(06)80016-6 |
1 |
|
| 2007 |
Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy. 3: 374-6. PMID 17438366 |
0.96 |
|
| 2007 |
Criollo A, Vicencio JM, Tasdemir E, Maiuri MC, Lavandero S, Kroemer G. The inositol trisphosphate receptor in the control of autophagy. Autophagy. 3: 350-3. PMID 17404493 |
0.96 |
|
| 2007 |
Galluzzi L, Zamzami N, de La Motte Rouge T, Lemaire C, Brenner C, Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 12: 803-13. PMID 17294081 DOI: 10.1007/s10495-007-0720-1 |
1 |
|
| 2007 |
Braun T, Carvalho G, Grosjean J, Ades L, Fabre C, Boehrer S, Debili N, Fenaux P, Kroemer G. Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation. Apoptosis : An International Journal On Programmed Cell Death. 12: 1101-8. PMID 17245643 DOI: 10.1007/s10495-006-0030-z |
0.68 |
|
| 2007 |
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, ... ... Kroemer G, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine. 13: 54-61. PMID 17187072 DOI: 10.1038/nm1523 |
0.64 |
|
| 2007 |
Criollo A, Galluzzi L, Maiuri MC, Tasdemir E, Lavandero S, Kroemer G. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis : An International Journal On Programmed Cell Death. 12: 3-18. PMID 17080328 DOI: 10.1007/s10495-006-0328-x |
1 |
|
| 2006 |
Tesniere A, Zitvogel L, Kroemer G. The immune system: taming and unleashing cancer. Discovery Medicine. 6: 211-6. PMID 17250785 |
0.88 |
|
| 2006 |
Poncet D, Pauleau AL, Szabadkai G, Vozza A, Scholz SR, Le Bras M, Brière JJ, Jalil A, Le Moigne R, Brenner C, Hahn G, Wittig I, Schägger H, Lemaire C, Bianchi K, ... ... Kroemer G, et al. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. The Journal of Cell Biology. 174: 985-96. PMID 16982800 DOI: 10.1083/jcb.200604069 |
0.64 |
|
| 2006 |
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nature Reviews. Immunology. 6: 715-27. PMID 16977338 DOI: 10.1038/nri1936 |
0.88 |
|
| 2006 |
Coquelle A, Mouhamad S, Pequignot MO, Braun T, Carvalho G, Vivet S, Métivier D, Castedo M, Kroemer G. Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis. Biochemical Pharmacology. 72: 1396-404. PMID 16765323 DOI: 10.1016/j.bcp.2006.04.014 |
0.96 |
|
| 2006 |
Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, Kiladjian JJ, Ribrag V, Fenaux P, Kroemer G. NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 107: 1156-65. PMID 16223780 DOI: 10.1182/blood-2005-05-1989 |
0.68 |
|
| 2005 |
Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, ... ... Kroemer G, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. The Journal of Experimental Medicine. 202: 1691-701. PMID 16365148 DOI: 10.1084/jem.20050915 |
0.96 |
|
| 2005 |
Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N, Perfettini JL, Djavaheri-Mergny M, Youlyouz-Marfak I, Codogno P, Raphael M, Feuillard J, Kroemer G. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene. 24: 7503-13. PMID 16091749 DOI: 10.1038/sj.onc.1208907 |
0.76 |
|
| 2005 |
González-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquère S, Eskelinen EL, Pierron G, Saftig P, Kroemer G. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. Journal of Cell Science. 118: 3091-102. PMID 15985464 DOI: 10.1242/jcs.02447 |
0.76 |
|
| 2005 |
Zamzami N, Kroemer G. p53 in apoptosis control: an introduction. Biochemical and Biophysical Research Communications. 331: 685-7. PMID 15865922 DOI: 10.1016/j.bbrc.2005.04.013 |
1 |
|
| 2005 |
Perfettini JL, Roumier T, Kroemer G. Mitochondrial fusion and fission in the control of apoptosis. Trends in Cell Biology. 15: 179-83. PMID 15817372 DOI: 10.1016/j.tcb.2005.02.005 |
1 |
|
| 2005 |
Perfettini JL, Castedo M, Nardacci R, Ciccosanti F, Boya P, Roumier T, Larochette N, Piacentini M, Kroemer G. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. The Journal of Experimental Medicine. 201: 279-89. PMID 15642743 DOI: 10.1084/jem.20041502 |
1 |
|
| 2004 |
Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G. Viral proteins targeting mitochondria: controlling cell death. Biochimica Et Biophysica Acta. 1659: 178-89. PMID 15576050 DOI: 10.1016/j.bbabio.2004.08.007 |
1 |
|
| 2004 |
Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino PG, Pequignot MO, Casares N, Lazar V, Feraud O, Debili N, Wissing S, Engelhardt S, Madeo F, ... ... Kroemer G, et al. AIF deficiency compromises oxidative phosphorylation. The Embo Journal. 23: 4679-89. PMID 15526035 DOI: 10.1038/sj.emboj.7600461 |
0.64 |
|
| 2004 |
Andreau K, Castedo M, Perfettini JL, Roumier T, Pichart E, Souquere S, Vivet S, Larochette N, Kroemer G. Preapoptotic chromatin condensation upstream of the mitochondrial checkpoint. The Journal of Biological Chemistry. 279: 55937-45. PMID 15498771 DOI: 10.1074/jbc.M406411200 |
1 |
|
| 2004 |
Wissing S, Ludovico P, Herker E, Büttner S, Engelhardt SM, Decker T, Link A, Proksch A, Rodrigues F, Corte-Real M, Fröhlich KU, Manns J, Candé C, Sigrist SJ, Kroemer G, et al. An AIF orthologue regulates apoptosis in yeast. The Journal of Cell Biology. 166: 969-74. PMID 15381687 DOI: 10.1083/jcb.200404138 |
0.64 |
|
| 2004 |
Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5665-9. PMID 15355891 DOI: 10.1158/1078-0432.CCR-04-0415 |
0.68 |
|
| 2004 |
Candé C, Vahsen N, Métivier D, Tourrière H, Chebli K, Garrido C, Tazi J, Kroemer G. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. Journal of Cell Science. 117: 4461-8. PMID 15316071 DOI: 10.1242/jcs.01356 |
0.96 |
|
| 2004 |
Gallego MA, Joseph B, Hemström TH, Tamiji S, Mortier L, Kroemer G, Formstecher P, Zhivotovsky B, Marchetti P. Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas. Oncogene. 23: 6282-91. PMID 15286713 DOI: 10.1038/sj.onc.1207835 |
0.52 |
|
| 2004 |
Zamzami N, Kroemer G. Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis. Methods in Molecular Biology (Clifton, N.J.). 282: 103-15. PMID 15105559 DOI: 10.1385/1-59259-812-9:103 |
1 |
|
| 2004 |
Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 23: 2825-37. PMID 15077146 DOI: 10.1038/sj.onc.1207528 |
1 |
|
| 2004 |
Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, Vainchenker W, Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy Oncogene. 23: 4362-4370. PMID 15048075 DOI: 10.1038/sj.onc.1207572 |
0.64 |
|
| 2004 |
Castedo M, Perfettini JL, Roumier T, Yakushijin K, Horne D, Medema R, Kroemer G. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe Oncogene. 23: 4353-4361. PMID 15048074 DOI: 10.1038/sj.onc.1207573 |
0.64 |
|
| 2004 |
Poncet D, Larochette N, Pauleau AL, Boya P, Jalil AA, Cartron PF, Vallette F, Schnebelen C, Bartle LM, Skaletskaya A, Boutolleau D, Martinou JC, Goldmacher VS, Kroemer G, Zamzami N. An anti-apoptotic viral protein that recruits Bax to mitochondria. The Journal of Biological Chemistry. 279: 22605-14. PMID 15004026 DOI: 10.1074/jbc.M308408200 |
1 |
|
| 2004 |
Perfettini JL, Roumier T, Castedo M, Larochette N, Boya P, Raynal B, Lazar V, Ciccosanti F, Nardacci R, Penninger J, Piacentini M, Kroemer G. NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. The Journal of Experimental Medicine. 199: 629-40. PMID 14993250 DOI: 10.1084/jem.20031216 |
1 |
|
| 2004 |
Candé C, Vahsen N, Kouranti I, Schmitt E, Daugas E, Spahr C, Luban J, Kroemer RT, Giordanetto F, Garrido C, Penninger JM, Kroemer G. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis Oncogene. 23: 1514-1521. PMID 14716299 DOI: 10.1038/sj.onc.1207279 |
0.64 |
|
| 2003 |
Castedo M, Perfettini JL, Andreau K, Roumier T, Piacentini M, Kroemer G. Mitochondrial apoptosis induced by the HIV-1 envelope. Annals of the New York Academy of Sciences. 1010: 19-28. PMID 15033690 |
1 |
|
| 2003 |
Schmitt E, Parcellier A, Gurbuxani S, Cande C, Hammann A, Morales MC, Hunt CR, Dix DJ, Kroemer RT, Giordanetto F, Jäättelä M, Penninger JM, Pance A, Kroemer G, Garrido C. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Research. 63: 8233-40. PMID 14678980 |
0.56 |
|
| 2003 |
Gurbuxani S, Schmitt E, Cande C, Parcellier A, Hammann A, Daugas E, Kouranti I, Spahr C, Pance A, Kroemer G, Garrido C. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 22: 6669-6678. PMID 14555980 |
0.64 |
|
| 2003 |
Roumier T, Castedo M, Perfettini JL, Andreau K, Métivier D, Zamzami N, Kroemer G. Mitochondrion-dependent caspase activation by the HIV-1 envelope. Biochemical Pharmacology. 66: 1321-9. PMID 14555204 |
1 |
|
| 2003 |
Garrido C, Schmitt E, Candé C, Vahsen N, Parcellier A, Kroemer G. HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle (Georgetown, Tex.). 2: 579-84. PMID 14512773 |
0.68 |
|
| 2003 |
Zhu C, Qiu L, Wang X, Hallin U, Candé C, Kroemer G, Hagberg H, Blomgren K. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. Journal of Neurochemistry. 86: 306-17. PMID 12871572 |
0.68 |
|
| 2003 |
Badley AD, Roumier T, Lum JJ, Kroemer G. Mitochondrion-mediated apoptosis in HIV-1 infection. Trends in Pharmacological Sciences. 24: 298-305. PMID 12823956 DOI: 10.1016/S0165-6147(03)00125-1 |
1 |
|
| 2003 |
Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 22: 3927-36. PMID 12813466 DOI: 10.1038/sj.onc.1206622 |
1 |
|
| 2003 |
Ferrand-Drake M, Zhu C, Gidö G, Hansen AJ, Karlsson JO, Bahr BA, Zamzami N, Kroemer G, Chan PH, Wieloch T, Blomgren K. Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. Journal of Neurochemistry. 85: 1431-42. PMID 12787063 DOI: 10.1046/j.1471-4159.2003.01794.x |
0.64 |
|
| 2003 |
Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion Journal of Experimental Medicine. 197: 1323-1334. PMID 12756268 DOI: 10.1084/jem.20021952 |
0.64 |
|
| 2003 |
Boya P, Roumier T, Andreau K, Gonzalez-Polo RA, Zamzami N, Castedo M, Kroemer G. Mitochondrion-targeted apoptosis regulators of viral origin. Biochemical and Biophysical Research Communications. 304: 575-81. PMID 12729592 |
1 |
|
| Show low-probability matches. |